Organic metal compound, organic light-emitting device including the organic metal compound, and electronic device including the organic light-emitting device

By using organometallic compounds with specific structures as emission layer materials in organic light-emitting devices, the problem of insufficient material performance in hole and electron transport regions has been solved, thereby improving luminous efficiency and lifetime.

CN112851638BActive Publication Date: 2024-11-15SAMSUNG ELECTRONICS CO LTD
View PDF 12 Cites 0 Cited by

Patent Information

Application Number
CN202011368197.6
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2020-11-25
Filing Date
2020-11-27
Publication Date
2024-11-15
Estimated Expiration
2040-11-27

AI Technical Summary

Technical Problem

In existing organic light-emitting devices, the material properties of the hole and electron transport regions are insufficient, which leads to the need to improve the luminous efficiency and lifetime of the devices.

Method used

By using organometallic compounds with specific structures as emitter layer materials, the transport efficiency of holes and electrons can be improved and the chemical and electrical stability of the device can be enhanced by controlling their ligand structure and bonding mode.

Benefits of technology

This improves the luminous efficiency and lifetime of organic light-emitting devices while maintaining excellent chemical and electrical stability.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN112851638B_ABST
    Figure CN112851638B_ABST
Patent Text Reader

Abstract

Provided are an organic metal compound, an organic light-emitting device including the organic metal compound, and an electronic device including the organic light-emitting device, wherein the organic metal compound is represented by Formula 1. Formula 1 can be understood by referring to the description of Formula 1 provided herein. Formula 1#imgabs0#
Need to check novelty before this filing date? Find Prior Art

Description

[0001] CROSS-REFERENCE TO RELATED APPLICATIONS

[0002] This application claims priority to and the benefit of Korean Patent Application No. 10-2019-0154355 filed on November 27, 2019, and Korean Patent Application No. 10-2020-0159546 filed on November 25, 2020, in the Korean Intellectual Property Office, the contents of which are incorporated herein by reference in their entirety. Technical Field

[0003] The present disclosure relates to an organometallic compound, an organic light-emitting device including the same, and an electronic device including the organic light-emitting device. Background Art

[0004] Organic light emitting devices (OLEDs) are self-emitting devices that produce full-color images. In addition, OLEDs have a wide viewing angle and exhibit excellent driving voltage and response speed characteristics.

[0005] A typical OLED includes an anode, a cathode, and an organic layer between the anode and the cathode and including an emission layer. A hole transport region may be between the anode and the emission layer, and an electron transport region may be between the emission layer and the cathode. Holes provided from the anode may move toward the emission layer through the hole transport region, and electrons provided from the cathode may move toward the emission layer through the electron transport region. Holes and electrons recombine in the emission layer to generate excitons. These excitons transition from an excited state to a ground state to thereby generate light. Summary of the invention

[0006] Provided are an organic metal compound, an organic light-emitting device including the organic metal compound, and an electronic device including the organic light-emitting device.

[0007] Additional aspects will be set forth in part in the description which follows and, in part, will be apparent from the description, or may be learned by practice of the provided embodiments of the disclosure.

[0008] According to an aspect of one embodiment, the organometallic compound is represented by Formula 1:

[0009] Formula 1

[0010]

[0011] Wherein, M in Formula 1 is a transition metal,

[0012] X in Formula 1 1 -X 4 are each independently C or N,

[0013] In formula 1, in X 1 The key between X2 The key between X 3 and M, and the key between X 4 Two of the bonds between and M are each coordinate bonds, and the remaining bonds may each be covalent bonds,

[0014] Z in Formula 1 1 -Z 4 Each is independently a group represented by Formula 2:

[0015] Formula 2

[0016]

[0017] b1-b4 in Formula 1 are each independently an integer of 0-20, and the sum of b1-b4 is 1 or greater,

[0018] Ring CY in Formula 1 1 To Ring CY 4 Each independently is C 5 -C 30 Carbocyclic group or C 1 -C 30 Heterocyclic groups,

[0019] T in Formula 1 1 For single bonds, double bonds, *-N(R 5a )-*'、*-B(R 5a )-*'、*-P(R 5a )-*'、*-C(R 5a )(R 5b )-*'、*-Si(R 5a )(R 5b )-*'、*-Ge(R 5a )(R 5b )-*', *-S-*', *-Se-*', *-O-*', *-C(=O)-*', *-S(=O)-*', *-S(=O) 2 -*'、*-C(R 5a )=*'、*=C(R 5a )-*'、*-C(R 5a )=C(R 5b )-*', *-C(=S)-*', *-C≡C-*', unsubstituted or substituted with at least one R 10a Substituted C 5 -C 30 A carbocyclic group, either unsubstituted or substituted with at least one R 10a Substituted C 1 -C 30 Heterocyclic groups,

[0020] T in Formula 12 For single bonds, double bonds, *-N(R 6a )-*'、*-B(R 6a )-*'、*-P(R 6a )-*'、*-C(R 6a )(R 6b )-*'、*-Si(R 6a )(R 6b )-*'、*-Ge(R 6a )(R 6b )-*', *-S-*', *-Se-*', *-O-*', *-C(=O)-*', *-S(=O)-*', *-S(=O) 2 -*'、*-C(R 6a )=*'、*=C(R 6a )-*'、*-C(R 6a )=C(R 6b )-*', *-C(=S)-*', *-C≡C-*', unsubstituted or substituted with at least one R 10a Substituted C 5 -C 30 A carbocyclic group, either unsubstituted or substituted with at least one R 10a Substituted C 1 -C 30 Heterocyclic groups,

[0021] T in Formula 1 3 For single bonds, double bonds, *-N(R 7a )-*'、*-B(R 7a )-*'、*-P(R 7a )-*'、*-C(R 7a )(R 7b )-*'、*-Si(R 7a )(R 7b )-*'、*-Ge(R 7a )(R 7b )-*', *-S-*', *-Se-*', *-O-*', *-C(=O)-*', *-S(=O)-*', *-S(=O) 2 -*'、*-C(R 7a )=*'、*=C(R 7a )-*'、*-C(R 7a )=C(R 7b )-*', *-C(=S)-*', *-C≡C-*', unsubstituted or substituted with at least one R 10a Substituted C 5 -C 30 A carbocyclic group, either unsubstituted or substituted with at least one R10a Substituted C 1 -C 30 Heterocyclic groups,

[0022] T in Formula 1 4 For single bonds, double bonds, *-N(R 8a )-*'、*-B(R 8a )-*'、*-P(R 8a )-*'、*-C(R 8a )(R 8b )-*'、*-Si(R 8a )(R 8b )-*'、*-Ge(R 8a )(R 8b )-*', *-S-*', *-Se-*', *-O-*', *-C(=O)-*', *-S(=O)-*', *-S(=O) 2 -*'、*-C(R 8a )=*'、*=C(R 8a )-*'、*-C(R 8a )=C(R 8b )-*', *-C(=S)-*', *-C≡C-*', unsubstituted or substituted with at least one R 10a Substituted C 5 -C 30 A carbocyclic group, either unsubstituted or substituted with at least one R 10a Substituted C 1 -C 30 Heterocyclic groups,

[0023] In Formula 1, n1-n4 are each independently an integer of 0-5, and at least three of n1-n4 are each independently an integer of 1-5,

[0024] In formula 1, when n1 is 0, T 1 does not exist. When n2 is 0, T 2 does not exist. When n3 is 0, T 3 does not exist, and when n4 is 0, T 4 does not exist,

[0025] In Formula 1, when n1 is 2 or greater, at least two T 1 The same or different from each other, when n2 is 2 or greater, at least two T 2 The same or different from each other, when n3 is 2 or greater, at least two T 3 are the same as or different from each other, and when n4 is 2 or greater, at least two T 4 Same or different from each other,

[0026] R in formula 1 and 21 -R 4 , R 5a , R 5b , R 6a , R 6b , R 7a , R 7b , R 8a , R 8b , and Q 51 -Q 53 are independently hydrogen, deuterium, -F, -Cl, -Br, -I, -SF 5 , hydroxyl, cyano, nitro, amidine, hydrazine, hydrazone, carboxylic acid or its salt, sulfonic acid or its salt, phosphoric acid or its salt, substituted or unsubstituted C 1 -C 60 Alkyl, substituted or unsubstituted C 2 -C 60 Alkenyl, substituted or unsubstituted C 2 -C 60 Alkynyl, substituted or unsubstituted C 1 -C 60 Alkoxy, substituted or unsubstituted C 1 -C 60 Alkylthio, substituted or unsubstituted C 3 -C 10 Cycloalkyl, substituted or unsubstituted C 1 -C 10 Heterocycloalkyl, substituted or unsubstituted C 3 -C 10 Cycloalkenyl, substituted or unsubstituted C 2 -C 10 Heterocycloalkenyl, substituted or unsubstituted unsaturated C 1 -C 10 Heterocyclic group, substituted or unsubstituted C 6 -C 60 Aryl, substituted or unsubstituted C 7 -C 60 Alkaryl, substituted or unsubstituted C 6 -C 60 Aryloxy, substituted or unsubstituted C 6 -C 60 Arylthio, substituted or unsubstituted C 1 -C 60 Heteroaryl, substituted or unsubstituted C 2 -C 60 alkylheteroaryl, substituted or unsubstituted monovalent non-aromatic fused polycyclic group, substituted or unsubstituted monovalent non-aromatic fused heteropolycyclic group, -N(Q 1 )(Q 2 )、-Si(Q 3 )(Q4 )(Q 5 )、-Ge(Q 3 )(Q 4 )(Q 5 )、-B(Q 6 )(Q 7 )、-P(=O)(Q 8 )(Q 9 ), or -P(Q 8 )(Q 9 ), and Q in Eq. 2 51 -Q 53 None can be hydrogen,

[0027] Q in Formula 2 51 -Q 53 At least one of which is independently substituted or unsubstituted C 6 -C 60 Aryl, substituted or unsubstituted C 1 -C 60 a heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, or a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group,

[0028] a1-a4 in Formula 1 are each independently an integer of 0-20,

[0029] L in Formula 2 1 is a single bond, is unsubstituted or is replaced by at least one R 10a Substituted C 5 -C 30 A carbocyclic group, either unsubstituted or substituted with at least one R 10a Substituted C 1 -C 30 Heterocyclic groups,

[0030] In formula 2, c1 is an integer from 1 to 10.

[0031] c2 in Formula 2 is an integer from 1 to 20,

[0032] The number a1 in formula 1 is R 1 At least two of which are optionally combined to form an unsubstituted or substituted R 10a Substituted C 5 -C 30 The carbocyclic group is either unsubstituted or substituted with at least one R 10a Substituted C 1 -C 30 Heterocyclic groups,

[0033] The number a2 in formula 1 is R 2 At least two of which are optionally combined to form an unsubstituted or substituted R 10a Substituted C5 -C 30 The carbocyclic group is either unsubstituted or substituted with at least one R 10a Substituted C 1 -C 30 Heterocyclic groups,

[0034] The number of R in formula 1 is a3 3 At least two of which are optionally combined to form an unsubstituted or substituted R 10a Substituted C 5 -C 30 The carbocyclic group is either unsubstituted or substituted with at least one R 10a Substituted C 1 -C 30 Heterocyclic groups,

[0035] The number of R in formula 1 is a4 4 At least two of which are optionally combined to form an unsubstituted or substituted R 10a Substituted C 5 -C 30 The carbocyclic group is either unsubstituted or substituted with at least one R 10a Substituted C 1 -C 30 Heterocyclic groups,

[0036] R 1 -R 4 , R 5a , R 5b , R 6a , R 6b , R 7a , R 7b , R 8a , and R 8b At least two of which are optionally combined to form an unsubstituted or substituted R 10a Substituted C 5 -C 30 The carbocyclic group is either unsubstituted or substituted with at least one R 10a Substituted C 1 -C 30 Heterocyclic groups,

[0037] R 10a By referring to the R 1 Descriptive understanding,

[0038] * and *' each represent a binding site to an adjacent atom, and

[0039] Substituted C 1 -C 60 Alkyl, substituted C 2 -C 60 Alkenyl, substituted C2 -C 60 Alkynyl, substituted C 1 -C 60 Alkoxy, substituted C 1 -C 60 Alkylthio, substituted C 3 -C 10 Cycloalkyl, substituted C 1 -C 10 Heterocycloalkyl, substituted C 3 -C 10 Cycloalkenyl, substituted C 2 -C 10 Heterocycloalkenyl, substituted unsaturated C 1 -C 10 Heterocyclic groups, substituted C 6 -C 60 Aryl, substituted C 7 -C 60 Alkaryl, substituted C 6 -C 60 Aryloxy, substituted C 6 -C 60 Arylthio, substituted C 1 -C 60 Heteroaryl, substituted C 2 -C 60 The substituents of the alkyl heteroaryl group, the substituted monovalent non-aromatic condensed polycyclic group, and the substituted monovalent non-aromatic condensed heteropolycyclic group are:

[0040] Deuterium, -F, -Cl, -Br, -I, -CD 3 、-CD 2 H.-CDH 2 , -CF 3 , -CF 2 H, -CFH 2 , hydroxyl, cyano, nitro, amino, amidine, hydrazine, hydrazone, carboxylic acid or its salt, sulfonic acid or its salt, phosphoric acid or its salt, C 1 -C 60 Alkyl, C 2 -C 60 Alkenyl, C 2 -C 60 Alkynyl, or C 1 -C 60 Alkoxy;

[0041] Each of C is substituted by 1 -C 60 Alkyl, C 2 -C 60 Alkenyl, C 2 -C 60 Alkynyl, or C1 -C 60 Alkoxy: deuterium, -F, -Cl, -Br, -I, -CD 3 、-CD 2 H.-CDH 2 , -CF 3 , -CF 2 H, -CFH 2 , hydroxyl, cyano, nitro, amino, amidine, hydrazine, hydrazone, carboxylic acid or its salt, sulfonic acid or its salt, phosphoric acid or its salt, C 3 -C 10 Cycloalkyl, C 1 -C 10 Heterocycloalkyl, C 3 -C 10 Cycloalkenyl, C 2 -C 10 Heterocycloalkenyl, unsaturated C 1 -C 10 Heterocyclic group, C 6 -C 60 Aryl, C 6 -C 60 Aryloxy, C 6 -C 60 Arylthio, C 1 -C 60 heteroaryl, monovalent non-aromatic fused polycyclic group, monovalent non-aromatic fused heteropolycyclic group, -N(Q 11 )(Q 12 )、-Si(Q 13 )(Q 14 )(Q 15 )、-Ge(Q 13 )(Q 14 )(Q 15 )、-B(Q 16 )(Q 17 )、-P(=O)(Q 18 )(Q 19 )、-P(Q 18 )(Q 19 ), or any combination thereof;

[0042] Each C is unsubstituted or substituted as follows 3 -C 10 Cycloalkyl, C 1 -C 10 Heterocycloalkyl, C 3 -C 10 Cycloalkenyl, C 2 -C 10 Heterocycloalkenyl, unsaturated C 1 -C 10 Heterocyclic group, C 6-C 60 Aryl, C 6 -C 60 Aryloxy, C 6 -C 60 Arylthio, C 1 -C 60 Heteroaryl, monovalent non-aromatic fused polycyclic group, or monovalent non-aromatic fused heteropolycyclic group: deuterium, -F, -Cl, -Br, -I, -CD 3 、-CD 2 H.-CDH 2 , -CF 3 , -CF 2 H, -CFH 2 , hydroxyl, cyano, nitro, amino, amidine, hydrazine, hydrazone, carboxylic acid or its salt, sulfonic acid or its salt, phosphoric acid or its salt, C 1 -C 60 Alkyl, C 2 -C 60 Alkenyl, C 2 -C 60 Alkynyl, C 1 -C 60 Alkoxy, C 3 -C 10 Cycloalkyl, C 1 -C 10 Heterocycloalkyl, C 3 -C 10 Cycloalkenyl, C 2 -C 10 Heterocycloalkenyl, unsaturated C 1 -C 10 Heterocyclic group, C 6 -C 60 Aryl, C 6 -C 60 Aryloxy, C 6 -C 60 Arylthio, C 1 -C 60 heteroaryl, monovalent non-aromatic fused polycyclic group, monovalent non-aromatic fused heteropolycyclic group, -N(Q 21 )(Q 22 )、-Si(Q 23 )(Q 24 )(Q 25 )、-Ge(Q 23 )(Q 24 )(Q 25 )、-B(Q 26 )(Q 27 )、-P(=O)(Q 28 )(Q 29 )、-P(Q 28 )(Q29 ), or any combination thereof;

[0043] -N(Q 31 )(Q 32 )、-Si(Q 33 )(Q 34 )(Q 35 )、-Ge(Q 33 )(Q 34 )(Q 35 )、-B(Q 36 )(Q 37 )、-P(=O)(Q 38 )(Q 39 ), or -P(Q 38 )(Q 39 );or

[0044] Any combination of

[0045] Where Q 1 -Q 9 , Q 11 -Q 19 , Q 21 -Q 29 , and Q 31 -Q 39 independently hydrogen; deuterium; -F; -Cl; -Br; -I; hydroxyl; cyano; nitro; amidino; hydrazine; hydrazone; carboxylic acid group or its salt; sulfonic acid group or its salt; phosphoric acid group or its salt; unsubstituted or substituted with deuterium, C 1 -C 60 Alkyl, C 6 -C 60 Aryl, or any combination thereof substituted C 1 -C 60 Alkyl; C 2 -C 60 Alkenyl; C 2 -C 60 Alkynyl; C 1 -C 60 Alkoxy; C 3 -C 10 Cycloalkyl; C 1 -C 10 Heterocycloalkyl; C 3 -C 10 Cycloalkenyl; C 2 -C 10 Heterocycloalkenyl; unsaturated C 1 -C 10 Heterocyclic group; unsubstituted or substituted with deuterium, C 1 -C 60 Alkyl, C 6 -C 60Aryl, or any combination thereof substituted C 6 -C 60 Aryl; C 6 -C 60 Aryloxy; C 6 -C 60 Arylthio; C 1 -C 60 heteroaryl; a monovalent non-aromatic fused polycyclic group; or a monovalent non-aromatic fused heteropolycyclic group.

[0046] According to an aspect of another embodiment, an organic light emitting device may include: a first electrode; a second electrode; and an organic layer disposed between the first electrode and the second electrode and including an emission layer, wherein the organic layer may include at least one organic metal compound represented by Formula 1.

[0047] The organic metal compound may be included in the emission layer of the organic layer, and the organic metal compound included in the emission layer may serve as a dopant.

[0048] According to an aspect of another embodiment, provided is an electronic device including the organic light emitting device. BRIEF DESCRIPTION OF THE DRAWINGS

[0049] The above and other aspects, features and advantages of some embodiments of the present disclosure will become more apparent from the following description considered in conjunction with the accompanying drawings, in which:

[0050] Figure 1 is a schematic cross-sectional view of an organic light emitting device according to an exemplary embodiment. DETAILED DESCRIPTION

[0051] Embodiments will now be described in detail, examples of which are illustrated in the accompanying drawings, wherein the same reference numerals refer to the same elements throughout. In this regard, the present embodiment may have different forms and should not be construed as being limited to the description set forth herein. Therefore, the following only describes the embodiments to illustrate aspects by reference to the accompanying drawings. As used herein, the term "and / or" includes any and all combinations of one or more of the related enumerated items. Expressions such as "at least one (kind)" when before or after a list of elements modify the entire list of elements and do not modify the individual elements of the list.

[0052] It will be understood that when an element is referred to as being “on” another element, it can be directly on the other element or intervening elements may be present therebetween. In contrast, when an element is referred to as being “directly on” another element, there are no intervening elements present.

[0053] It will be understood that although the terms "first", "second", "third", etc. may be used herein to describe various elements, components, regions, layers and / or parts, these elements, components, regions, layers and / or parts should not be limited by these terms. These terms are only used to distinguish one element, component, region, layer or part from another element, component, region, layer or part. Therefore, without departing from the teachings herein, the "first element", "component", "region", "layer" or "part" discussed below may be referred to as a second element, component, region, layer or part.

[0054] The terms used herein are for the purpose of describing specific embodiments only and are not intended to be limiting. As used herein, "a, an" and "the" do not represent a limit on quantity and are intended to cover both the singular and the plural, unless the context clearly states otherwise. For example, "an element" has the same meaning as "at least one element", unless the context clearly states otherwise.

[0055] "Or" means "and / or". As used herein, the term "and / or" includes any and all combinations of one or more of the relevant listed items. It will be further understood that the terms "comprise" or "include" when used in this specification indicate the presence of the stated features, regions, integers, steps, operations, elements and / or components, but do not exclude the presence or addition of one or more additional features, regions, integers, steps, operations, elements, components, and / or their collections.

[0056] In addition, relative terms such as "lower" or "bottom" and "upper" or "top" may be used herein to describe the relationship of one element to another element as shown in the figure. It will be understood that, in addition to the orientation shown in the figure, relative terms are also intended to include different orientations of the device. For example, if the device in one of the figures is turned over, the element described as being on the "lower" side of the other element will be oriented on the "upper" side of the other element. Therefore, depending on the specific orientation of the figure, the exemplary term "lower" may include both "lower" and "upper" orientations. Similarly, if the device in one of the figures is turned over, the element described as "below" or "below" the other element will be oriented "above" the other element. Therefore, the exemplary terms "below..." or "below..." may include both "above..." and "below..." orientations.

[0057] As used herein, "about" or "approximately" is inclusive of the stated value and means within an acceptable range of deviation for the particular value as determined by one of ordinary skill in the art taking into account the measurement in question and the errors associated with the measurement of the particular quantity (i.e., the limitations of the measurement system). For example, "about" can mean within one or more standard deviations, or within ±10% or 5% relative to the stated value.

[0058] Unless otherwise defined, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the present disclosure belongs. It will be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having the same meaning as they have in the context of the present disclosure and the relevant art, and will not be interpreted in an idealized or overly formal sense unless clearly so defined herein.

[0059] Exemplary embodiments are described herein with reference to cross-sectional views as schematic diagrams of idealized embodiments. Thus, deviations from the shapes of the figures as a result of, for example, manufacturing techniques and / or tolerances are to be expected. Therefore, the embodiments described herein should not be construed as being limited to the specific shapes of the regions as illustrated herein, but rather include deviations in shape caused by, for example, manufacturing. For example, a region illustrated or described as flat may typically have rough and / or nonlinear features. Moreover, the illustrated sharp corners may be rounded. Therefore, the regions illustrated in the figures are schematic in nature and their shapes are not intended to illustrate the precise shapes of the regions and are not intended to limit the scope of the claims.

[0060] According to one aspect, the organometallic compound can be represented by Formula 1:

[0061] Formula 1

[0062]

[0063] Wherein, in Formula 1, M may be a transition metal.

[0064] In some embodiments, M can be a first row transition metal, a second row transition metal, or a third row transition metal of the periodic table.

[0065] In some embodiments, M may be iridium (Ir), platinum (Pt), osmium (Os), titanium (Ti), zirconium (Zr), hafnium (Hf), europium (Eu), terbium (Tb), thulium (Tm), rhodium (Rh), palladium (Pd), or gold (Au).

[0066] In some embodiments, M in Formula 1 may be Pt, Pd, or Au.

[0067] In formula 1, X 1 -X4 They may each independently be C or N.

[0068] In some embodiments, X 2 and X 3 Can be C, and X 4 Can be N. In some embodiments, X 1 -X 3 Can be C, and X 4 Can be N.

[0069] In formula 1, in X 1 The key between X 2 The key between X 3 and M, and the key between X 4 Two of the bonds between and M may each be coordinate bonds, and the remaining ones may each be covalent bonds.

[0070] In some embodiments, in Formula 1, 1 The bond between X and M may be a coordination bond. 1 The bond between X and M may be a coordination bond and X 1 Can be C. Alternatively, in Formula 1, in X 1 The bond between X and M may be a coordination bond and X 1 Can be N.

[0071] In one or more embodiments, in Formula 1, X 1 The key between M and X 4 The bonds between X and M can each be coordination bonds, and 2 The key between M and X 3 The bonds between M and M may each be covalent bonds.

[0072] In one or more embodiments, in Formula 1,

[0073] X 2 and X 3 Can be C,

[0074] X 4 Can be N,

[0075] In X 2 The key between M and X 3 The bonds between and M may each be covalent bonds, and

[0076] In X 1 The key between M and X 4 The bonds between and M may each be coordinate bonds.

[0077] Z in Formula 1 1 -Z 4Each may be independently a group represented by Formula 2:

[0078] Formula 2

[0079]

[0080] Formula 2 can be understood by reference to its description provided herein.

[0081] In formula 1, b1-b4 can represent Z 1 -Z 4 The number of b1-b4 may be independently an integer of 0-20 (e.g., 0, 1, 2, or 3), wherein the sum of b1-b4 may be 1 or greater (e.g., 1, 2, 3, 4, 5, or 6). That is, the organometallic compound represented by Formula 1 may include at least one (e.g., one, two, three, four, five, or six) group represented by Formula 2. When b1 is 2 or greater, at least two Z 1 The groups may be the same or different from each other. When b2 is 2 or greater, at least two Z 2 The groups may be identical or different from each other. When b3 is 2 or greater, at least two Z 3 The groups may be the same or different from each other, and when b4 is 2 or greater, at least two Z 4 The groups may be the same as or different from each other.

[0082] In some embodiments, in Formula 1, b1 may be 0, 1, 2, or 3, and b2-b4 may be 0 or 1.

[0083] In some embodiments, in Formula 1, the sum of b1, b2, b3, and b4 may be 1, 2, or 3.

[0084] In some embodiments, in Formula 1,

[0085] i) b1 may be 1, 2 or 3, and b2, b3, and b4 may each be 0,

[0086] ii) b2 may be 1, and b1, b3, and b4 may each be 0,

[0087] iii) b3 may be 1, and b1, b2, and b4 may each be 0,

[0088] iv) b4 may be 1, and b1, b2, and b3 may be 0,

[0089] v) b1 may be 1 or 2, b2 may be 1, and b3 and b4 may each be 0,

[0090] vi) b1 may be 1 or 2, b3 may be 1, and b2 and b4 may each be 0,

[0091] vii) b1 may be 1 or 2, b4 may be 1, and b2 and b3 may each be 0,

[0092] viii) b1 may be 0, b2 may be 1, and b3 may be 1, and b4 may be 0,

[0093] ix) b1 may be 0, b2 may be 1, and b3 may be 0, and b4 may be 1, or

[0094] x) b1 may be 0, b2 may be 0, b3 may be 1, and b4 may be 1.

[0095] In Formula 1, ring CY 1 To Ring CY 4 Can be independently C 5 -C 30 Carbocyclic group or C 1 -C 30 Heterocyclic group.

[0096] In some embodiments, ring CY in Formula 1 1 To Ring CY 4 may each independently be i) a first ring, ii) a second ring, iii) a fused ring in which at least two first rings are fused, iv) a fused ring in which at least two second rings are fused, or v) a fused ring in which at least one first ring is fused with at least one second ring,

[0097] The first ring can be a cyclopentane group, a cyclopentadiene group, a furan group, a thiophene group, a pyrrole group, a thiole group, a boroheterocyclopentadiene group, a phosphole group, a germanoheterocyclopentadiene group, a selenophene group, Azole group, iso Azole group, 1,2,3- Oxazolyl group, 1,2,4- Oxadiazole group, 1,2,5- Oxadiazole group, 1,3,4- Oxadiazole group, Triazole group, iso a triazole group, a thiazole group, an isothiazole group, a 1,2,3-thiadiazole group, a 1,2,4-thiadiazole group, a 1,2,5-thiadiazole group, a 1,3,4-thiadiazole group, a thiatriazole group, an isothiatriazole group, a pyrazole group, an imidazole group, a 1,2,3-triazole group, a 1,2,4-triazole group, a tetrazole group, an azathiol group, a 1,2,3-diazathiol group, a 1,2,4-diazathiol group, a 1,2,5-diazathiol group, a 1,3,4-diazathiol group, or a triazathiol group, and

[0098] The second ring may be an adamantane group, a norbornane group, a norbornene group, a cyclohexane group, a cyclohexene group, a cyclohexadiene group, a phenyl group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a 1,3,5-triazine group, a 1,2,3-triazine group, a 1,2,4-triazine group, a 1,2- Oxazine group, 1,3- Oxazine group, 1,4- an oxazine group, a 1,2-thiazine group, a 1,3-thiazine group, a 1,4-thiazine group, a dihydropyrazine group, a dihydropyridine group, or a dihydroazasilole group.

[0099] In some embodiments, ring CY in Formula 1 1 may be i) a first ring, ii) a fused ring in which at least two first rings are fused, or iii) a fused ring in which at least one first ring is fused with at least one second ring, and the ring CY 1 The C or N in the first ring in formula 1 may be X 1 That is, including in the ring CY 1 The first ring (eg, 5-membered ring) in Formula 1 may be bonded to M in Formula 1. The first ring and the second ring may be understood by referring to the description of the first ring and the second ring provided herein, respectively.

[0100] In one or more embodiments, in Formula 1, ring CY 1 To Ring CY 4 may be independently a cyclopentane group, a cyclopentene group, a cyclohexane group, a cyclohexene group, a cyclohexadiene group, a phenyl group, a naphthalene group, an anthracene group, a phenanthrene group, a benzo[9,10]phenanthrene group, a pyrene group, group, cyclopentadiene group, 1,2,3,4-tetrahydronaphthalene group, thiophene group, furan group, boroheterocyclopentadiene group, phosphocyclopentadiene group, germanocyclopentadiene group, selenophene group, indole group, benzoborole group, benzophosphocyclopentadiene group, indene group, benzothiole group, benzogermanocyclopentadiene group, benzothiophene group, benzoselenophene group, benzofuran group, carbazole group, dibenzoborole group group, dibenzophosphole group, fluorene group, dibenzosilole group, dibenzogermanol group, dibenzothiophene group, dibenzoselenophene group, dibenzofuran group, dibenzothiophene 5-oxide group, 9H-fluorene-9-one group, dibenzothiophene 5,5-dioxide group, azaindole group, azabenzoborole group, azabenzophosphole group, azaindene group, azabenzosilole group, Azabenzogermanium heterocyclopentadiene group, azabenzothiophene group, azabenzoselenophene group, azabenzofuran group, azacarbazole group, azadibenzoborole group, azadibenzophosphole group, azafluorene group, azadibenzosilole group, azadibenzogermanium heterocyclopentadiene group, azadibenzothiophene group, azadibenzoselenophene group, azadibenzofuran group, azadibenzothiophene 5-oxide group, aza-9H-fluoren-9-one group, azadibenzothiophene 5,5-dioxide group, pyridine group, pyrimidine group, pyrazine group, pyridazine group, 1,3,5-triazine group, 1,2,3-triazine group, 1,2,4-triazine group, quinoline group, isoquinoline group, quinoxaline group, quinazoline group, phenanthroline group, pyrrole group, pyrazole group, imidazole group, 1,2,3-triazole group, 1,2,4-triazole group, Azole group, iso azole group, thiazole group, isothiazole group, oxadiazole group, thiadiazole group, benzopyrazole group, benzimidazole group, benzo Azole group, benzothiazole group, benzo a oxadiazole group, a benzothiadiazole group, a 5,6,7,8-tetrahydroisoquinoline group, a 5,6,7,8-tetrahydroquinoline group, an adamantane group, a norbornane group, or a norbornene group.

[0101] In one or more embodiments, in Formula 1, ring CY 1 It can be a pyrazole group, an imidazole group, a 1,2,3-triazole group, a 1,2,4-triazole group, Azole group, iso azole group, thiazole group, isothiazole group, oxadiazole group, thiadiazole group, benzopyrazole group, benzimidazole group, benzo Azole group, benzothiazole group, benzo a oxadiazole group, a benzothiadiazole group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a 1,3,5-triazine group, a 1,2,3-triazine group, a 1,2,4-triazine group, a quinoline group, an isoquinoline group, a quinoxaline group, a quinazoline group, a 5,6,7,8-tetrahydroisoquinoline group, or a 5,6,7,8-tetrahydroquinoline group.

[0102] In one or more embodiments, in Formula 1, ring CY 2 and CY 3 Each of them may independently be a benzene group, a naphthyl group, a carbazole group, a fluorene group, a dibenzosilole group, a dibenzothiophene group, a dibenzofuran group, an azacarbazole group, an azafluorene group, an azadibenzosilole group, an azadibenzothiophene group, an azadibenzofuran group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a 1,3,5-triazine group, a 1,2,3-triazine group, a 1,2,4-triazine group, a quinoline group, an isoquinoline group, a quinoxaline group, a quinazoline group, a 5,6,7,8-tetrahydroisoquinoline group, or a 5,6,7,8-tetrahydroquinoline group.

[0103] In one or more embodiments, in Formula 1, ring CY 4 The benzoic acid group may be independently a benzene group, a naphthyl group, a carbazole group, a fluorene group, a dibenzosilole group, a dibenzothiophene group, a dibenzofuran group, an azacarbazole group, an azafluorene group, an azadibenzosilole group, an azadibenzothiophene group, an azadibenzofuran group, a pyridine group, a pyrimidine group, a pyrazine group, a pyridazine group, a 1,3,5-triazine group, a 1,2,3-triazine group, a 1,2,4-triazine group, a quinoline group, an isoquinoline group, a quinoxaline group, a quinazoline group, a 5,6,7,8-tetrahydroisoquinoline group, a 5,6,7,8-tetrahydroquinoline group, a benzimidazole group, a benzo an oxazole group, or a benzothiazole group.

[0104] In formula 1, T 1 Can be single bond, double bond, *-N(R 5a )-*'、*-B(R 5a )-*'、*-P(R 5a )-*'、*-C(R 5a )(R 5b )-*'、*-Si(R 5a )(R 5b )-*'、*-Ge(R 5a )(R 5b )-*', *-S-*', *-Se-*', *-O-*', *-C(=O)-*', *-S(=O)-*', *-S(=O) 2-*'、*-C(R 5a )=*'、*=C(R 5a )-*'、*-C(R 5a )=C(R 5b )-*', *-C(=S)-*', *-C≡C-*', unsubstituted or substituted with at least one R 10a Substituted C 5 -C 30 A carbocyclic group, either unsubstituted or substituted with at least one R 10a Substituted C 1 -C 30 Heterocyclic group, T 2 Can be single bond, double bond, *-N(R 6a )-*'、*-B(R 6a )-*'、*-P(R 6a )-*'、*-C(R 6a )(R 6b )-*'、*-Si(R 6a )(R 6b )-*'、*-Ge(R 6a )(R 6b )-*', *-S-*', *-Se-*', *-O-*', *-C(=O)-*', *-S(=O)-*', *-S(=O) 2 -*'、*-C(R 6a )=*'、*=C(R 6a )-*'、*-C(R 6a )=C(R 6b )-*', *-C(=S)-*', *-C≡C-*', unsubstituted or substituted with at least one R 10a Substituted C 5 -C 30 A carbocyclic group, either unsubstituted or substituted with at least one R 10a Substituted C 1 -C 30 Heterocyclic group, T 3 Can be single bond, double bond, *-N(R 7a )-*'、*-B(R 7a )-*'、*-P(R 7a )-*'、*-C(R 7a )(R 7b )-*'、*-Si(R 7a )(R 7b )-*'、*-Ge(R 7a )(R 7b)-*', *-S-*', *-Se-*', *-O-*', *-C(=O)-*', *-S(=O)-*', *-S(=O) 2 -*'、*-C(R 7a )=*'、*=C(R 7a )-*'、*-C(R 7a )=C(R 7b )-*', *-C(=S)-*', *-C≡C-*', unsubstituted or substituted with at least one R 10a Substituted C 5 -C 30 A carbocyclic group, either unsubstituted or substituted with at least one R 10a Substituted C 1 -C 30 Heterocyclic group, and T 4 Can be single bond, double bond, *-N(R 8a )-*'、*-B(R 8a )-*'、*-P(R 8a )-*'、*-C(R 8a )(R 8b )-*'、*-Si(R 8a )(R 8b )-*'、*-Ge(R 8a )(R 8b )-*', *-S-*', *-Se-*', *-O-*', *-C(=O)-*', *-S(=O)-*', *-S(=O) 2 -*'、*-C(R 8a )=*'、*=C(R 8a )-*'、*-C(R 8a )=C(R 8b )-*', *-C(=S)-*', *-C≡C-*', unsubstituted or substituted with at least one R 10a Substituted C 5 -C 30 A carbocyclic group, either unsubstituted or substituted with at least one R 10a Substituted C 1 -C 30 Heterocyclic group. 5a , R 5b , R 6a , R 6b , R 7a , R 7b , R 8a , and R 8b can be respectively referred to the R provided in this article 5a , R 5b , R 6a , R6b , R 7a , R 7b , R 8a , and R 8b Description understanding.

[0105] In one or more embodiments, in Formula 1, T 1 Can be *-N(R 5a )-*'、*-B(R 5a )-*'、*-C(R 5a )(R 5b )-*'、*-Si(R 5a )(R 5b )-*', *-S-*', or *-O-*'.

[0106] In one or more embodiments, in Formula 1, T 2 Can be a single bond, *-N(R 6a )-*'、*-B(R 6a )-*'、*-C(R 6a )(R 6b )-*'、*-Si(R 6a )(R 6b )-*', *-S-*', or *-O-*'.

[0107] In one or more embodiments, in Formula 1, T 3 Can be a single bond.

[0108] In one or more embodiments, in Formula 1, T 4 Can be *-N(R 8a )-*'、*-B(R 8a )-*'、*-C(R 8a )(R 8b )-*'、*-Si(R 8a )(R 8b )-*', *-S-*', *-O-*', unsubstituted or substituted with at least one R 10a Substituted C 5 -C 30 A carbocyclic group, either unsubstituted or substituted with at least one R 10a Substituted C 1 -C 30 Heterocyclic group.

[0109] n1 to n4 in Formula 1 may each independently be an integer of 0 to 5, and at least three of n1 to n4 may each independently be an integer of 1 to 5. That is, the organometallic compound represented by Formula 1 may be a tetradentate ligand.

[0110] In one or more embodiments, in Formula 1, i) n1 may be 0, and n2, n3 and n4 may each independently be an integer of 1-5, ii) n2 may be 0, and n1, n3 and n4 may each independently be an integer of 1-5, iii) n3 may be 0, and n1, n2 and n4 may each independently be an integer of 1-5, iv) n4 may be 0, and n1, n2 and n3 may each independently be an integer of 1-5, or v) n1, n2, n3 and n4 may each independently be an integer of 1-5.

[0111] In formula 1, when n1 is 0, T 1 It may not exist. When n2 is 0, T 2 It may not exist. When n3 is 0, T 3 may not exist, and when n4 is 0, T 4 But it doesn't exist.

[0112] In Formula 1, when n1 is 2 or greater, at least two T 1 may be the same or different from each other. When n2 is 2 or greater, at least two T 2 can be the same or different from each other. When n3 is 2 or greater, at least two T 3 may be the same as or different from each other, and when n4 is 2 or greater, at least two T 4 Can be the same as or different from each other.

[0113] In some embodiments, in Formula 1,

[0114] 1) n4 may be 0, and n1, n2, and n3 may be 1,

[0115] 2) n4 may be 1, 2, 3, or 4, and n1, n2, and n3 may each be 1,

[0116] 3) n3 may be 0, n1 and n2 may each be 1, and n4 may be 1, 2, 3, or 4,

[0117] 4) n2 may be 0, n1 and n3 may each be 1, and n4 may be 1, 2, 3, or 4, or

[0118] 5) n1 may be 0, n2 and n3 may each be 1, and n4 may be 1, 2, 3, or 4.

[0119] In some embodiments, in Formula 1, n1 and n3 may each be different from 0.

[0120] In some embodiments, in Formula 1, n1 may not be 0 (eg, n1 may be 1), and T 1 Can be *-N(R 5a )-*'、*-B(R 5a )-*'、*-P(R5a )-*'、*-C(R 5a )(R 5b )-*'、*-Si(R 5a )(R 5b )-*'、*-Ge(R 5a )(R 5b )-*', *-S-*', or *-O-*'.

[0121] In one or more embodiments, in Formula 1, n2 may not be 0 (eg, n2 may be 1), and T 2 Can be a single bond.

[0122] In one or more embodiments, in Formula 1, n2 may not be 0 (eg, n2 may be 1), and T 2 Can be *-N(R 6a )-*'、*-B(R 6a )-*'、*-P(R 6a )-*'、*-C(R 6a )(R 6b )-*'、*-Si(R 6a )(R 6b )-*'、*-Ge(R 6a )(R 6b )-*', *-S-*', or *-O-*'.

[0123] In one or more embodiments, in Formula 1, n3 may not be 0 (eg, n3 may be 1), and T 3 Can be a single bond.

[0124] In one or more embodiments, in Formula 1, n4 may be 0.

[0125] In one or more embodiments, in Formula 1, n4 may not be 0, and T 4 Can be *-N(R 8a )-*'、*-B(R 8a )-*'、*-P(R 8a )-*'、*-C(R 8a )(R 8b )-*'、*-Si(R 8a )(R 8b )-*'、*-Ge(R 8a )(R 8b )-*', *-S-*', *-Se-*', *-O-*', *-C(=O)-*', *-S(=O)-*', *-S(=O) 2 -*'、*-C(R 8a )=*'、*=C(R 8a)-*'、*-C(R 8a )=C(R 8b )-*', *-C(=S)-*', *-C≡C-*', unsubstituted or substituted with at least one R 10a Substituted C 5 -C 30 A carbocyclic group, either unsubstituted or substituted with at least one R 10a Substituted C 1 -C 30 Heterocyclic group.

[0126] In one or more embodiments, in Formula 1, n4 may be 1, 2, 3, or 4, and T 4 Can be *-C(R 8a )(R 8b )-*', *-S-*', *-O-*', or is unsubstituted or replaced by at least one R 10a Substituted C 5 -C 30 Carbocyclic group.

[0127] In formulas 1 and 2, R 1 -R 4 , R 5a , R 5b , R 6a , R 6b , R 7a , R 7b , R 8a , R 8b , and Q 51 -Q 53 can be independently hydrogen, deuterium, -F, -Cl, -Br, -I, -SF 5 , hydroxyl, cyano, nitro, amidine, hydrazine, hydrazone, carboxylic acid or its salt, sulfonic acid or its salt, phosphoric acid or its salt, substituted or unsubstituted C 1 -C 60 Alkyl, substituted or unsubstituted C 2 -C 60 Alkenyl, substituted or unsubstituted C 2 -C 60 Alkynyl, substituted or unsubstituted C 1 -C 60 Alkoxy, substituted or unsubstituted C 1 -C 60 Alkylthio, substituted or unsubstituted C 3 -C 10 Cycloalkyl, substituted or unsubstituted C 1 -C 10 Heterocycloalkyl, substituted or unsubstituted C 3 -C 10Cycloalkenyl, substituted or unsubstituted C 2 -C 10 Heterocycloalkenyl, substituted or unsubstituted unsaturated C 1 -C 10 Heterocyclic group, substituted or unsubstituted C 6 -C 60 Aryl, substituted or unsubstituted C 7 -C 60 Alkaryl, substituted or unsubstituted C 6 -C 60 Aryloxy, substituted or unsubstituted C 6 -C 60 Arylthio, substituted or unsubstituted C 1 -C 60 Heteroaryl, substituted or unsubstituted C 2 -C 60 alkylheteroaryl, substituted or unsubstituted monovalent non-aromatic fused polycyclic group, substituted or unsubstituted monovalent non-aromatic fused heteropolycyclic group, -N(Q 1 )(Q 2 )、-Si(Q 3 )(Q 4 )(Q 5 )、-Ge(Q 3 )(Q 4 )(Q 5 )、-B(Q 6 )(Q 7 )、-P(=O)(Q 8 )(Q 9 ), or -P(Q 8 )(Q 9 ), where Q in Formula 2 51 -Q 53 None of them can be hydrogen, and Q in Formula 2 51 -Q 53 At least one (e.g., Q 51 -Q 53 One or two of ) may be independently substituted or unsubstituted C 6 -C 60 Aryl, substituted or unsubstituted C 1 -C 60 A heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, or a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group. 51 -Q 53 None of them can be hydrogen.

[0128] In some embodiments, R 1 -R 4 , R 5a , R 5b , R6a , R 6b , R 7a , R 7b , R 8a , R 8b , and Q 51 -Q 53 Can be independently:

[0129] hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl, cyano, nitro, amino, amidino, hydrazine, hydrazone, carboxylic acid group or its salt, sulfonic acid group or its salt, phosphoric acid group or its salt, -SF 5 , C 1 -C 20 Alkyl, C 2 -C 20 Alkenyl, C 1 -C 20 Alkoxy, or C 1 -C 20 Alkylthio;

[0130] Each of C is substituted by 1 -C 20 Alkyl, C 2 -C 20 Alkenyl, C 1 -C 20 Alkoxy, or C 1 -C 20 Alkylthio: deuterium, -F, -Cl, -Br, -I, -CD 3 、-CD 2 H.-CDH 2 , -CF 3 , -CF 2 H, -CFH 2 , hydroxyl, cyano, nitro, amino, amidine, hydrazine, hydrazone, carboxylic acid or its salt, sulfonic acid or its salt, phosphoric acid or its salt, C 1 -C 10 alkyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, adamantyl, norbornyl, norbornenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, cyclooctenyl, cyclopentadienyl, cyclohexadienyl, cycloheptadienyl, cyclooctadienyl, cycloheptatrienyl, cyclooctatrienyl, bicyclo[1.1.1]pentyl, bicyclo[2.1.1]hexyl, bicyclo[2.2.2]octyl, bicyclo[2.2.2]octenyl, bicyclo[2.2.2]octadienyl, bicyclo[2.2.2]octatrienyl, (C 1 -C 20 alkyl)cyclopentyl, (C 1 -C 20 alkyl)cyclohexyl, (C 1 -C 20alkyl)cycloheptyl, (C 1 -C 20 Alkyl)cyclooctyl, (C 1 -C 20 Alkyl) adamantyl, (C 1 -C 20 Alkyl) norbornyl, (C 1 -C 20 Alkyl) norbornene, (C 1 -C 20 alkyl)cyclopentenyl, (C 1 -C 20 alkyl)cyclohexenyl, (C 1 -C 20 alkyl)cycloheptenyl, (C 1 -C 20 alkyl)cyclopentadienyl, (C 1 -C 20 alkyl)cyclohexadienyl, (C 1 -C 20 alkyl)cycloheptadienyl, (C 1 -C 20 alkyl)cyclooctadienyl, (C 1 -C 20 alkyl)cycloheptatrienyl, (C 1 -C 20 alkyl)cyclooctadienyl, (C 1 -C 20 alkyl)bicyclo[1.1.1]pentyl, (C 1 -C 20 alkyl)bicyclo[2.1.1]hexyl, (C 1 -C 20 alkyl)bicyclo[2.2.2]octyl, (C 1 -C 20 alkyl)bicyclo[2.2.2]octadienyl, (C 1 -C 20 alkyl) bicyclo[2.2.2]octatrienyl, phenyl, (C 1 -C 20 alkyl)phenyl, biphenyl, terphenyl, naphthyl, pyridyl, pyrimidinyl, or any combination thereof;

[0131] cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, adamantyl, norbornyl, norbornenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, cyclooctenyl, cyclopentadienyl, cyclohexadienyl, cycloheptadienyl, cyclooctadienyl, cycloheptatrienyl, cyclooctatrienyl, bicyclo[1.1.1]pentyl, bicyclo[2.1.1]hexyl, bicyclo[2.2.2]octyl, bicyclo[2.2.2]octenyl, bicyclo[2.2.2]octadienyl, bicyclo[2.2.2]octatrienyl, phenyl, (C 1 -C 20 alkyl)phenyl, biphenyl, terphenyl, naphthyl, fluorenyl, phenanthryl, anthracenyl, fluoranthenyl, benzo[9,10]phenanthryl, pyrenyl, yl, pyrrolyl, thienyl, furyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, Azolyl, iso oxazolyl, pyridinyl, pyrazinyl, pyrimidinyl, pyridazinyl, isoindolyl, indolyl, indazolyl, purinyl, quinolyl, isoquinolyl, benzoquinolyl, quinoxalinyl, quinazolinyl, cinnolinyl, carbazolyl, phenanthrolinyl, benzimidazolyl, benzofuranyl, benzothiophenyl, isobenzothiazolyl, benzo Azolyl, isobenzo Azolyl, triazolyl, tetrazolyl, oxadiazolyl, triazine, dibenzofuranyl, dibenzothiophenyl, benzocarbazolyl, dibenzocarbazolyl, imidazopyridinyl, imidazopyrimidinyl, azacarbazolyl, azadibenzofuranyl, or azadibenzothiophenyl: deuterium, -F, -Cl, -Br, -I, -CD 3 、-CD 2 H.-CDH 2 , -CF 3 , -CF 2 H, -CFH 2 , hydroxyl, cyano, nitro, amino, amidine, hydrazine, hydrazone, carboxylic acid or its salt, sulfonic acid or its salt, phosphoric acid or its salt, C 1 -C 20 Alkyl, deuterated C 2 -C 20 Alkyl, C 1 -C 20 alkoxy, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, adamantyl, norbornyl, norbornenyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, cyclooctenyl, cyclopentadienyl, cyclohexadienyl, cycloheptadienyl, cyclooctadienyl, cycloheptatrienyl, cyclooctatrienyl, bicyclo[1.1.1]pentyl, bicyclo[2.1.1]hexyl, bicyclo[2.2.2]octyl, bicyclo[2.2.2]octenyl, bicyclo[2.2.2]octadienyl, bicyclo[2.2.2]octatrienyl, (C1 -C 20 alkyl)cyclopentyl, (C 1 -C 20 alkyl)cyclohexyl, (C 1 -C 20 alkyl)cycloheptyl, (C 1 -C 20 Alkyl)cyclooctyl, (C 1 -C 20 Alkyl) adamantyl, (C 1 -C 20 Alkyl) norbornyl, (C 1 -C 20 Alkyl) norbornene, (C 1 -C 20 alkyl)cyclopentenyl, (C 1 -C 20 alkyl)cyclohexenyl, (C 1 -C 20 alkyl)cycloheptenyl, (C 1 -C 20 alkyl)cyclopentadienyl, (C 1 -C 20 alkyl)cyclohexadienyl, (C 1 -C 20 alkyl)cycloheptadienyl, (C 1 -C 20 alkyl)cyclooctadienyl, (C 1 -C 20 alkyl)cycloheptatrienyl, (C 1 -C 20 alkyl)cyclooctadienyl, (C 1 -C 20 alkyl)bicyclo[1.1.1]pentyl, (C 1 -C 20 alkyl)bicyclo[2.1.1]hexyl, (C 1 -C 20 alkyl)bicyclo[2.2.2]octyl, phenyl, (C 1 -C 20 alkyl)phenyl, biphenyl, terphenyl, naphthyl, fluorenyl, phenanthryl, anthracenyl, fluoranthenyl, benzo[9,10]phenanthryl, pyrenyl, yl, pyrrolyl, thienyl, furyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, Azolyl, iso oxazolyl, pyridinyl, pyrazinyl, pyrimidinyl, pyridazinyl, isoindolyl, indolyl, indazolyl, purinyl, quinolyl, isoquinolyl, benzoquinolyl, quinoxalinyl, quinazolinyl, cinnolinyl, carbazolyl, phenanthrolinyl, benzimidazolyl, benzofuranyl, benzothiophenyl, isobenzothiazolyl, benzo Azolyl, isobenzo Azolyl, triazolyl, tetrazolyl, oxadiazole, triazine, dibenzofuranyl, dibenzothiophenyl, benzocarbazolyl, dibenzocarbazolyl, imidazopyridyl, imidazopyrimidyl, azacarbazolyl, azadibenzofuranyl, azadibenzothiophenyl, or any combination thereof; or

[0132] -N(Q 1 )(Q 2 )、-Si(Q 3 )(Q 4 )(Q 5 )、-Ge(Q 3 )(Q 4 )(Q 5 )、-B(Q 6 )(Q 7 )、-P(=O)(Q 8 )(Q 9 ), or -P(Q 8 )(Q 9 ),

[0133] Where Q 1 -Q 9 Can be independently:

[0134] Deuterium, -F, -CH 3 、-CD 3 、-CD 2 H.-CDH 2 、-CH 2 CH 3 、-CH 2 CD 3 、-CH 2 CD 2 H, -CH 2 CDH 2 、-CHDCH 3 、-CHDCD 2 H, -CHDCDH 2 、-CHDCD 3 、-CD 2 CD 3 、-CD 2 CD 2 H.-CD 2 CDH 2 , -CF 3 , -CF 2 H, -CFH 2 、-CH 2 CF 3 、-CH 2 CF 2H, -CH 2 CFH 2 、-CHFCH 3 , -CHFCF 2 H, -CHFCFH 2 , -CHFCF 3 , -CF 2 CF 3 , -CF 2 CF 2 H, or -CF 2 CFH 2 ;or

[0135] n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl, tert-pentyl, neopentyl, isopentyl, sec-pentyl, 3-pentyl, sec-isopentyl, phenyl, biphenyl, or naphthyl, each unsubstituted or substituted with: deuterium, -F, C 1 -C 10 Alkyl, phenyl, or any combination thereof.

[0136] In some embodiments, Q 51 -Q 53 may be independently substituted or unsubstituted C 1 -C 60 Alkyl, substituted or unsubstituted C 6 -C 60 Aryl, substituted or unsubstituted C 1 -C 60 heteroaryl, a substituted or unsubstituted monovalent non-aromatic fused polycyclic group, or a substituted or unsubstituted monovalent non-aromatic fused heteropolycyclic group, wherein Q 51 -Q 53 At least one (e.g., Q 51 -Q 53 One or both of ) may be substituted or unsubstituted C 6 -C 60 Aryl, substituted or unsubstituted C 1 -C 60 a heteroaryl group, a substituted or unsubstituted monovalent non-aromatic condensed polycyclic group, or a substituted or unsubstituted monovalent non-aromatic condensed heteropolycyclic group.

[0137] In one or more embodiments,

[0138] Q 51 -Q 53 may be each independently unsubstituted or substituted by C 1 -C 20 Alkyl, phenyl, (C 1 -C 20alkyl)phenyl, biphenyl, terphenyl, naphthyl, fluorenyl, phenanthryl, anthracenyl, fluoranthenyl, benzo[9,10]phenanthryl, pyrenyl, yl, pyrrolyl, thienyl, furyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, Azolyl, iso oxazolyl, pyridinyl, pyrazinyl, pyrimidinyl, pyridazinyl, isoindolyl, indolyl, indazolyl, purinyl, quinolyl, isoquinolyl, benzoquinolyl, quinoxalinyl, quinazolinyl, cinnolinyl, carbazolyl, phenanthrolinyl, benzimidazolyl, benzofuranyl, benzothiophenyl, isobenzothiazolyl, benzo Azolyl, isobenzo Azolyl, triazolyl, tetrazolyl, oxadiazolyl, triazine, dibenzofuranyl, dibenzothiophenyl, benzocarbazolyl, dibenzocarbazolyl, imidazopyridinyl, imidazopyrimidinyl, azacarbazolyl, azadibenzofuranyl, or azadibenzothiophenyl: deuterium, -F, -Cl, -Br, -I, -CD 3 、-CD 2 H.-CDH 2 , -CF 3 , -CF 2 H, -CFH 2 , hydroxyl, cyano, nitro, amino, amidine, hydrazine, hydrazone, carboxylic acid or its salt, sulfonic acid or its salt, phosphoric acid or its salt, C 1 -C 10 Alkyl, phenyl, (C 1 -C 20 alkyl)phenyl, biphenyl, terphenyl, naphthyl, pyridyl, pyrimidyl, or any combination thereof,

[0139] Where Q 51 -Q 53 At least one (e.g., Q 51 -Q 53 One or two of ) may be phenyl, (C 1 -C 20 alkyl)phenyl, biphenyl, terphenyl, naphthyl, fluorenyl, phenanthryl, anthracenyl, fluoranthenyl, benzo[9,10]phenanthryl, pyrenyl, yl, pyrrolyl, thienyl, furyl, imidazolyl, pyrazolyl, thiazolyl, isothiazolyl, Azolyl, iso oxazolyl, pyridinyl, pyrazinyl, pyrimidinyl, pyridazinyl, isoindolyl, indolyl, indazolyl, purinyl, quinolyl, isoquinolyl, benzoquinolyl, quinoxalinyl, quinazolinyl, cinnolinyl, carbazolyl, phenanthrolinyl, benzimidazolyl, benzofuranyl, benzothiophenyl, isobenzothiazolyl, benzo Azolyl, isobenzo Azolyl, triazolyl, tetrazolyl, oxadiazolyl, triazine, dibenzofuranyl, dibenzothiophenyl, benzocarbazolyl, dibenzocarbazolyl, imidazopyridinyl, imidazopyrimidinyl, azacarbazolyl, azadibenzofuranyl, or azadibenzothiophenyl: deuterium, -F, -Cl, -Br, -I, -CD 3 、-CD 2 H.-CDH 2 , -CF 3 , -CF 2 H, -CFH 2 , hydroxyl, cyano, nitro, amino, amidine, hydrazine, hydrazone, carboxylic acid or its salt, sulfonic acid or its salt, phosphoric acid or its salt, C 1 -C 10 Alkyl, phenyl, (C 1 -C 20 alkyl)phenyl, biphenyl, terphenyl, naphthyl, pyridyl, pyrimidinyl, or any combination thereof.

[0140] In one or more embodiments, in Formulas 1 and 2, R 1 -R 4 , R 5a , R 5b , R 6a , R 6b , R 7a , R 7b , R 8a , R 8b , and Q 51 -Q 53 can be independently hydrogen, deuterium, -F, -CH 3 、-CD 3 、-CD 2 H.-CDH 2 , -CF 3 , -CF 2 H, -CFH 2 , C 2 -C 10 Alkenyl, C 1 -C 10 Alkoxy, C 1 -C 10an alkylthio group, a group represented by one of formulae 9-1 to 9-39, a group represented by one of formulae 9-1 to 9-39 in which at least one hydrogen is replaced by deuterium, a group represented by one of formulae 9-1 to 9-39 in which at least one hydrogen is replaced by -F, a group represented by one of formulae 9-201 to 9-237, a group represented by one of formulae 9-201 to 9-237 in which at least one hydrogen is replaced by deuterium, a group represented by one of formulae 9-201 to 9-237 in which at least one hydrogen is replaced by -F, a group represented by one of formulae 10-1 to 10-1 a group represented by one of the formulae 10-1 to 10-129 in which at least one hydrogen is replaced by deuterium, a group represented by one of the formulae 10-1 to 10-129 in which at least one hydrogen is replaced by -F, a group represented by one of the formulae 10-201 to 10-350, a group represented by one of the formulae 10-201 to 10-350 in which at least one hydrogen is replaced by deuterium, a group represented by one of the formulae 10-201 to 10-350 in which at least one hydrogen is replaced by -F, -Si(Q 3 )(Q 4 )(Q 5 ), or -Ge(Q 3 )(Q 4 )(Q 5 )(where Q 3 -Q 5 can be respectively referred to the Q provided in this article 3 -Q 5 The description of the understanding), where Q in formula 2 51 -Q 53 None can be hydrogen and Q 51 -Q 53 Each may be independently a group represented by one of formulae 10-12 to 10-129, a group represented by one of formulae 10-12 to 10-129 in which at least one hydrogen is replaced by deuterium, a group represented by one of formulae 10-12 to 10-129 in which at least one hydrogen is replaced by -F, a group represented by one of formulae 10-201 to 10-350, a group represented by one of formulae 10-201 to 10-350 in which at least one hydrogen is replaced by deuterium, or a group represented by one of formulae 10-201 to 10-350 in which at least one hydrogen is replaced by -F:

[0141]

[0142]

[0143]

[0144]

[0145]

[0146]

[0147]

[0148]

[0149]

[0150] In one or more embodiments, in Formula 2, Q 51 -Q 53 Can be independently -CH 3 、-CD 3 、-CD 2 H.-CDH 2 , -CF 3 , -CF 2 H, -CFH 2 , a group represented by one of formulae 9-1 to 9-39, a group represented by one of formulae 9-1 to 9-39 in which at least one hydrogen is replaced by deuterium, a group represented by one of formulae 9-1 to 9-39 in which at least one hydrogen is replaced by -F, a group represented by one of formulae 10-12 to 10-129, a group represented by one of formulae 10-1 to 10-129 in which at least one hydrogen is replaced by deuterium, or a group represented by one of formulae 10-1 to 10-129 in which at least one hydrogen is replaced by -F.

[0151] In one or more embodiments, Q 51 -Q 53 At least one (e.g., Q 51 -Q 53 10-12 to 10-129, a group represented by one of formulae 10-1 to 10-129 in which at least one hydrogen is replaced by deuterium, or a group represented by one of formulae 10-1 to 10-129 in which at least one hydrogen is replaced by -F.

[0152] In formulae 9-1 to 9-39, 9-201 to 9-237, 10-1 to 10-129, and 10-201 to 10-350, * may represent a bonding site with an adjacent atom, "Ph" represents a phenyl group, "TMS" represents a trimethylsilyl group, and "TMG" represents a trimethylgermyl group.

[0153] The “group represented by one of formulae 9-1 to 9-39 in which at least one hydrogen is replaced by deuterium” and the “group represented by one of formulae 9-201 to 9-237 in which at least one hydrogen is replaced by deuterium” may each be, for example, a group represented by one of formulae 9-501 to 9-514 and 9-601 to 9-636:

[0154]

[0155] The “group represented by one of formulae 9-1 to 9-39 in which at least one hydrogen is replaced by —F” and the “group represented by one of formulae 9-201 to 9-236 in which at least one hydrogen is replaced by —F” may each be, for example, a group represented by one of formulae 9-701 to 710:

[0156]

[0157] The “group represented by one of formulae 10-1 to 10-129 in which at least one hydrogen is replaced by a deuterium atom” and the “group represented by one of formulae 10-201 to 10-350 in which at least one hydrogen is replaced by a deuterium atom” may each be, for example, a group represented by one of formulae 10-501 to 553:

[0158]

[0159] The “group represented by one of formulae 10-1 to 10-129 in which at least one hydrogen is replaced by —F” and the “group represented by one of formulae 10-201 to 10-350 in which at least one hydrogen is replaced by —F” may each be, for example, a group represented by one of formulae 10-601 to 617:

[0160]

[0161] In formula 1, a1-a4 can represent R 1 -R 4 a1-a4 can each independently be an integer of 0-20 (e.g., 0, 1, 2, or 3). When a1 is 2 or greater, at least two R 1 The groups may be the same or different from each other. When a2 is 2 or greater, at least two R 2 The groups may be the same or different from each other. When a3 is 2 or greater, at least two R 3 The groups may be the same or different from each other, and when a4 is 2 or greater, at least two R 4 The groups may be the same as or different from each other.

[0162] In some embodiments, in Formula 1,

[0163] i) a1, a2, a3, and a4 may each be 0,

[0164] ii) a1 may be 1, 2 or 3, and a2, a3, and a4 may each be 0,

[0165] iii) a2 may be 1 or 2, and a1, a3, and a4 may each be 0,

[0166] iv) a3 may be 1 or 2, and a1, a2, and a4 may each be 0,

[0167] v) a4 may be 1 or 2, and a1, a2, and a3 may each be 0, or

[0168] vi) a1 and a4 may each be 1, and a2 and a3 may each be 0.

[0169] L in Formula 2 1 may be a single bond, unsubstituted or substituted with at least one R 10a Substituted C 5 -C 30 A carbocyclic group, either unsubstituted or substituted with at least one R 10a Substituted C 1 -C 30 Heterocyclic group.

[0170] In some embodiments, L in Formula 1 1 Can be:

[0171] a single key; or

[0172] Each is unsubstituted or replaced by at least one R 10a Substituted cyclopentene group, cyclohexane group, cyclohexene group, phenyl group, naphthalene group, anthracene group, phenanthrene group, benzo[9,10]phenanthrene group, pyrene group, group, cyclopentadiene group, 1,2,3,4-tetrahydronaphthalene group, thiophene group, furan group, indole group, benzoborole group, benzophosphole group, indene group, benzosilole group, benzogermanol group, benzothiophene group, benzoselenophene group, benzofuran group, carbazole group, dibenzoborole group, dibenzophosphole group, fluorene group, dibenzosilole group, dibenzogermanoyl group, dibenzothiophene group, dibenzoselenophene group, dibenzofuran group, dibenzothiophene 5-oxide group, 9H-fluoren-9-one group, dibenzothiophene 5,5-dioxide group, azaindole group, azabenzoborole group, azabenzophosphole group, azaindene group, azabenzosilole group, azabenzogermanoyl group, azabenzene aza-thiophene group, aza-benzoselenophene group, aza-benzofuran group, aza-carbazole group, aza-dibenzoborole group, aza-dibenzophosphole group, aza-fluorene group, aza-dibenzosilole group, aza-dibenzogermanol group, aza-dibenzothiophene group, aza-dibenzoselenophene group, aza-dibenzofuran group, aza-dibenzothiophene 5-oxide group, aza-9H-fluorene- 9-keto group, azadibenzothiophene 5,5-dioxide group, pyridine group, pyrimidine group, pyrazine group, pyridazine group, 1,3,5-triazine group, 1,2,3-triazine group, 1,2,4-triazine group, quinoline group, isoquinoline group, quinoxaline group, quinazoline group, phenanthroline group, pyrrole group, pyrazole group, imidazole group, 1,2,3-triazole group, 1,2,4-triazole group, Azole group, iso azole group, thiazole group, isothiazole group, oxadiazole group, thiadiazole group, benzopyrazole group, benzimidazole group, benzo Azole group, benzothiazole group, benzo a oxadiazole group, a benzothiadiazole group, a 5,6,7,8-tetrahydroisoquinoline group, a 5,6,7,8-tetrahydroquinoline group, an adamantane group, a norbornane group, or a norbornene group.

[0173] In some embodiments, L 1 Can be:

[0174] a single key; or

[0175] is unsubstituted or is replaced by at least one R 10a Substituted phenyl groups.

[0176] In formula 2, c1 can represent L 1 c1 can be an integer from 1 to 10 (e.g., 1, 2, or 3). When c1 is 2 or greater, at least two L 1Can be the same as or different from each other.

[0177] In formula 2, c2 can be represented by *-C(Q 51 )(Q 52 )(Q 53 )(where * indicates the adjacent L 1 The number of groups represented by *-C(Q) is represented by c2. c2 can be an integer from 1 to 20 (e.g., 1, 2, or 3). When c2 is 2 or greater, at least two of the groups represented by *-C(Q 51 )(Q 52 )(Q 53 ) may be the same as or different from each other.

[0178] In formula 1, 1) the number of R is a1 1 At least two of may be optionally combined to form an unsubstituted or substituted with at least one R 10a Substituted C 5 -C 30 The carbocyclic group is either unsubstituted or substituted with at least one R 10a Substituted C 1 -C 30 Heterocyclic group, 2) the number of R is a2 2 At least two of may be optionally combined to form an unsubstituted or substituted with at least one R 10a Substituted C 5 -C 30 The carbocyclic group is either unsubstituted or substituted with at least one R 10a Substituted C 1 -C 30 Heterocyclic group, 3) the number of R is a3 3 At least two of may be optionally combined to form an unsubstituted or substituted with at least one R 10a Substituted C 5 -C 30 The carbocyclic group is either unsubstituted or substituted with at least one R 10a Substituted C 1 -C 30 Heterocyclic group, 4) the number of R is a4 4 At least two of may be optionally combined to form an unsubstituted or substituted with at least one R 10a Substituted C 5 -C 30 The carbocyclic group is either unsubstituted or substituted with at least one R 10a Substituted C 1 -C 30 Heterocyclic group, 5) R 1 -R 4 , R 5a , R 5b , R 6a , R 6b , R7a , R 7b , R 8a , and R 8b At least two of may be optionally combined to form an unsubstituted or substituted with at least one R 10a Substituted C 5 -C 30 The carbocyclic group is either unsubstituted or substituted with at least one R 10a Substituted C 1 -C 30 Heterocyclic group.

[0179] As used in this article, R 10a By referring to the R 1 Description understanding.

[0180] In some embodiments, in Formula 1, n3 may not be 0, and the ring CY 1 It can be represented by one of the formulas CY1(1) to CY1(56) and CY1(101) to CY1(108):

[0181]

[0182]

[0183] Wherein, in formulas CY1(1) to CY1(56) and CY1(101) to CY1(108),

[0184] X 1 may be C or N, provided that X in formulas CY1(27) to CY1(39) and CY1(101) to CY1(108) 1 For C,

[0185] X 11 Can be O, S, N (R 18 )、C(R 18 )(R 19 ), or Si(R 18 )(R 19 ), and R 18 and R 19 Each can be referred to by referring to the R 1 Descriptive understanding,

[0186] * represents the binding site with M in Formula 1,

[0187] *' represents the difference between T and 3 The binding site, and

[0188] *" indicates the same as T in Formula 1 4 binding site.

[0189] In one or more embodiments, in Formula 1, n3 may not be 0, n4 may be 0, and The group represented by may be represented by one of the formulae CY1-1 to CY1-41 and CY1-Z1 to CY1-Z69:

[0190]

[0191]

[0192]

[0193]

[0194] Wherein, in formulas CY1-1 to CY1-41 and CY1-Z1 to CY1-Z69,

[0195] X 1 may be C or N, provided that X in formulas CY1-22 to CY1-41 and CY1-Z32 to CY1-Z69 1 For C,

[0196] R 1 and R 11 -R 15 Each can be referred to by referring to the R 1 The description of R 11 -R 15 Each of them may not be hydrogen,

[0197] Z 11 -Z 15 Each can be referred to by referring to Z provided herein 1 Descriptive understanding,

[0198] * represents the binding site with M in Formula 1, and

[0199] *' represents the difference between T and 3 binding site.

[0200] In one or more embodiments, in Formula 1, n1 may not be 0, n3 may not be 0, and the ring CY 2 It can be represented by one of the formulas CY2(1) to CY2(15):

[0201]

[0202] Wherein, in formulas CY2(1) to CY2(15),

[0203] X 2 Can be C or N,

[0204] X 21 Can be O, S, N (R 28 )、C(R 28 )(R 29 ), or Si(R 28 )(R 29 ), and R 28 and R 29 Each can be referred to by referring to the R 2 Descriptive understanding,

[0205] *' represents the difference between T and 3 The binding site

[0206] * represents the binding site with M in Formula 1, and

[0207] *" indicates the same as T in formula 1 1 binding site.

[0208] In one or more embodiments, in Formula 1, n1 may not be 0, n3 may not be 0, and The group represented by may be represented by one of the formulae CY2-1 to CY2-8 and CY2-Z1 to CY2-Z6:

[0209]

[0210] Wherein, in formulas CY2-1 to CY2-8 and CY2-Z1 to CY2-Z6,

[0211] X 1 Can be C or N,

[0212] R 2 and R 21 -R 23 Each can be referred to by referring to the R 2 The description of R 21 -R 23 Each of them may not be hydrogen,

[0213] Z 21 -Z 23 Each can be referred to by referring to Z provided herein 2 Descriptive understanding,

[0214] *' represents the difference between T and 3 The binding site

[0215] * represents the binding site with M in Formula 1, and

[0216] *" indicates the same as T in formula 1 1 binding site.

[0217] In one or more embodiments, in Formula 1, n1 may not be 0, n2 may not be 0, and the ring CY 3 It may be a group represented by the formula CY3-A or CY3-B:

[0218]

[0219] Wherein, in formula CY3-A and CY3-B,

[0220] X 3 and CY 3 can be respectively referred to the X provided in this article 3 and CY 3 Descriptive understanding,

[0221] Y 31 and Y 33 can be independently C or N and Y 32 It can be O, S, N, C, or Si,

[0222] In the formula CY3-A, X 3 and Y 33 The key between X 3 and Y 32 The key between 32 and Y 31 The bonds between X and X in formula CY3-B may each be a chemical bond (eg, a single bond or a double bond). 3 and Y 31 The key between and in X 3 and Y 33 The bond between may be a chemical bond (e.g., a single bond or a double bond),

[0223] *" indicates the same as T in formula 1 1 The binding site

[0224] * represents the binding site with M in Formula 1, and

[0225] *' represents the difference between T and 2 binding site.

[0226] In some embodiments, in Formula 1, n1 may not be 0, n2 may not be 0, and the ring CY 3 It may be a group represented by the formula CY3-A.

[0227] In one or more embodiments, in Formula 1, n2 may not be 0, n4 may be 0, and ring CY 4 It may be a group represented by the formula CY4-A or CY4-B:

[0228]

[0229] Wherein, in formula CY4-A and CY4-B,

[0230] X 4 and CY 4 Please refer to the X 4 and CY 4 Descriptive understanding,

[0231] Y 41 Can be C or N and Y 42 It can be O, S, N, C, or Si,

[0232] In the formula CY4-A, X 4 and Y 41 The bond between X and X in formula CY4-B may be a chemical bond (e.g., a single bond or a double bond). 4 and Y 42 The key between 42 and Y 41 The bonds between may each be chemical bonds (e.g., single bonds or double bonds),

[0233] * represents the binding site with M in Formula 1, and

[0234] *' represents the difference between T and 2 binding site.

[0235] In some embodiments, in Formula 1, n2 may not be 0, n4 may be 0, and the ring CY 4 It may be a group represented by CY4-A.

[0236] In some embodiments, in Formula 1, n2 may not be 0, T 1 Can be a single bond, n4 can be 0, ring CY 3 It may be a group represented by the formula CY3-A, and the ring CY 4 It may be a group represented by the formula CY4-A.

[0237] In some embodiments, in Formula 1, n2 may not be 0, T 1 Can be a single bond, n4 can be 0, ring CY 3 It may be a group represented by the formula CY3-B, and the ring CY 4 It may be a group represented by the formula CY4-B.

[0238] In some embodiments, in Formula 1, n2 may not be 0, T 1 It may not be a single bond, n4 may be 0, and the ring CY 3 It may be a group represented by the formula CY3-B, and the ring CY 4 It may be a group represented by the formula CY4-A.

[0239] In one or more embodiments, in Formula 1, n1 may not be 0, and the ring CY 3 It may be a group represented by one of the formulae CY3(1) to CY3(12) and CY3(101) to CY3(122):

[0240]

[0241]

[0242] Wherein, in formulas CY3(1) to CY3(12) and CY3(101) to CY3(122),

[0243] X 3 Can be C or N,

[0244] X 31 Can be single bond, O, S, N(R 38 )、C(R 38 )(R 39 ), or Si(R 38 )(R 39 ), X 32 Can be O, S, N (R 38 )、C(R 38 )(R 39 ), or Si(R 38 )(R 39 ), R 38 and R 39 Each can be referred to by referring to the R 3 Descriptive understanding,

[0245] *" indicates the same as T in formula 1 1 The binding site

[0246] * represents the binding site with M in Formula 1, and

[0247] *' represents the difference between T and 2 binding site.

[0248] In one or more embodiments, in Formula 1, n1 may not be 0, n2 may not be 0, and The group represented by may be represented by one of the formulae CY3-1 to CY3-16 and CY3-Z1 to CY3-Z10:

[0249]

[0250]

[0251] Wherein, in formulas CY3-1 to CY3-16 and CY3-Z1 to CY3-Z10,

[0252] X 3 Can be C or N,

[0253] R 3 and R 31 -R 36 Each can be referred to by referring to the R 3 The description of R 31 -R 36 Each of them may not be hydrogen,

[0254] Z 31 -Z 36 Each can be referred to by referring to Z provided herein 3 Descriptive understanding,

[0255] *" indicates the same as T in formula 1 1 The binding site

[0256] * represents the binding site with M in Formula 1, and

[0257] *' represents the difference between T and 2 binding site.

[0258] In one or more embodiments, in Formula 1, n2 may not be 0, and the ring CY 4 It may be a group represented by one of the formulae CY4(1) to CY4(42) and CY4(101) to CY4(111):

[0259]

[0260]

[0261] Wherein, in formulas CY4(1) to CY4(21) and CY4(101) to CY4(111),

[0262] X 4 Can be C or N,

[0263] X 41 Can be O, S, N (R 48 )、C(R 48 )(R 49 ), or Si(R 48 )(R 49 ), X 42 Can be single bond, O, S, N(R 48 )、C(R 48 )(R 49 ), or Si(R 48 )(R 49 ), and R 48 and R 49 Each can be referred to by referring to the R4 Descriptive understanding,

[0264] * represents the binding site with M in Formula 1,

[0265] *' represents the difference between T and 2 The binding site, and

[0266] *" indicates the same as T in Formula 1 4 binding site.

[0267] In one or more embodiments, in Formula 1, n2 may not be 0, n4 may be 0, and The group represented by may be represented by one of the formulae CY4-1 to CY4-24 and CY4-Z1 to CY4-Z8:

[0268]

[0269] Wherein, in formulas CY4-1 to CY4-24 and CY4-Z1 to CY4-Z8,

[0270] X 4 Can be C or N,

[0271] X 42 It can be understood by reference to the description provided herein that

[0272] R 4 and R 41 -R 44 Each can be referred to by referring to the R 4 The description of R 41 -R 44 Each of them may not be hydrogen,

[0273] Z 41 -Z 44 Each can be referred to by referring to Z provided herein 4 Descriptive understanding,

[0274] * represents the binding site with M in Formula 1, and

[0275] *' represents the difference between T and 2 binding site.

[0276] In one or more embodiments, the *-C(Q 51 )(Q 52 )(Q 53 ) is represented by one of formulae 2-1 to 2-20:

[0277]

[0278] Among them, in formulas 2-1 to 2-20, Q 51 , Q 52 and Q 61 -Q 65 may be independently substituted or unsubstituted C 1 -C 60 Alkyl or substituted or unsubstituted phenyl, wherein Q 51 , Q 52 , and Q 61 -Q 65 may be the same or different from each other, and * represents the same as L in Formula 2 1 binding site.

[0279] In some embodiments, in Formulas 2-1 to 2-20, Q 51 , Q 52 , and Q 61 -Q 65 may be each independently unsubstituted or substituted by C 1 -C 20 Alkyl or phenyl: deuterium, C 1 -C 20 Alkyl, phenyl, biphenyl, or any combination thereof.

[0280] In some embodiments, in the group represented by Formula 2, L 1 may be a single bond, and the group represented by Formula 2 may be represented by one of Formulae 2-1 to 2-20.

[0281] In some embodiments, Z 1 -Z 4 , Z 11 -Z 15 , Z 21 -Z 23 , Z 31 -Z 36 , and Z 41 -Z 44 Each can be independently represented by one of Formulas 2-1 to 2-20.

[0282] In one or more embodiments, L in Formula 2 1 may be a benzene group, c1 in Formula 2 may be 1, and the group represented by Formula 2 may be represented by one of Formulas 2(1) to 2(19):

[0283]

[0284] In formulas 2(1) to 2(19), T 11 -T 15 They can be respectively represented by *-C(Q51 )(Q 52 )(Q 53 ) represents a group, T 11 -T 15 can be the same or different from each other, R 10a The R 1 The description is understood, and * represents the ring CY in Formula 1 1 To Ring CY 4 at least one binding site of.

[0285] In some embodiments, Z 1 -Z 4 , Z 11 -Z 15 , Z 21 -Z 23 , Z 31 -Z 36 , and Z 41 -Z 44 Each can be independently represented by one of Formulae 2(1) to 2(19).

[0286] In one or more embodiments, the organometallic compound represented by Formula 1 may satisfy at least one of Conditions 1 to 4:

[0287] Condition 1

[0288] In Formula 1, n3 may not be 0, n4 may be 0, and The group represented can be represented by one of the formulae CY1-Z1 to CY1-Z69.

[0289] Condition 2

[0290] In Formula 1, n1 may not be 0, n3 may not be 0, and The group represented can be represented by one of the formulae CY2-Z1 to CY2-Z6.

[0291] Condition 3

[0292] In formula 1, n1 may not be 0, n2 may not be 0, and The group represented can be represented by one of the formulae CY3-Z1 to CY3-Z10.

[0293] Condition 4

[0294] In Formula 1, n2 may not be 0, n4 may be 0, and The group represented can be represented by one of the formulae CY4-Z1 to CY4-Z8.

[0295] In one or more embodiments, the organometallic compound represented by Formula 1 may emit blue light.

[0296] In one or more embodiments, the organometallic compound represented by Formula 1 may be one of the following compounds. Compounds Pt-2, Pt-3, Pt-13, Pt-17, Pt-18, and Pt-21 are the same as compounds 4, 2009, 2076, 2132, 2133, and 2187, respectively:

[0297]

[0298]

[0299]

[0300]

[0301]

[0302]

[0303]

[0304]

[0305]

[0306]

[0307]

[0308]

[0309]

[0310]

[0311]

[0312]

[0313]

[0314]

[0315]

[0316]

[0317]

[0318]

[0319]

[0320]

[0321]

[0322]

[0323]

[0324]

[0325]

[0326]

[0327]

[0328]

[0329]

[0330]

[0331]

[0332]

[0333]

[0334]

[0335]

[0336]

[0337]

[0338]

[0339]

[0340]

[0341]

[0342]

[0343]

[0344]

[0345]

[0346]

[0347]

[0348]

[0349]

[0350]

[0351]

[0352]

[0353]

[0354]

[0355]

[0356]

[0357]

[0358]

[0359]

[0360]

[0361]

[0362]

[0363]

[0364]

[0365]

[0366]

[0367]

[0368]

[0369]

[0370]

[0371]

[0372]

[0373]

[0374]

[0375]

[0376]

[0377]

[0378]

[0379]

[0380]

[0381]

[0382]

[0383]

[0384]

[0385]

[0386]

[0387]

[0388]

[0389]

[0390]

[0391]

[0392]

[0393]

[0394]

[0395]

[0396]

[0397]

[0398]

[0399]

[0400]

[0401]

[0402]

[0403]

[0404]

[0405]

[0406]

[0407]

[0408] In the organometallic compound represented by Formula 1, Z 1 -Z 4 may be independently a group represented by Formula 2, and each represents Z 1 -Z 4 The sum of the number of b1-b4 may be 1 or more. That is, the organic metal compound represented by Formula 1 may include at least one group represented by Formula 2. Therefore, the organic metal compound represented by Formula 1 may have an improved orientation (orientation) without a change in conjugation length. In addition, the group represented by *-C(Q 51 )(Q 52 )(Q 53 ) may not include hydrogen at the benzylic site including a weak chemical bond (ie, Q in Formula 1 51 -Q 53 None of them may be hydrogen). Therefore, the organometallic compound including at least one group represented by Formula 2 may have excellent chemical and / or electrical stability. Therefore, an electronic device such as an organic light-emitting device including the organometallic compound represented by Formula 1 may have improved luminous efficiency and lifespan.

[0409] The highest occupied molecular orbital (HOMO) energy level, the lowest unoccupied molecular orbital (LUMO) energy level, S1 Energy level, and T 1 The results are shown in Table 1.

[0410] Table 1

[0411]

[0412]

[0413] Referring to the results shown in Table 1, it was found that the organometallic compound represented by Formula 1 had suitable electrical characteristics for use as an emission layer material in an electronic device such as an organic light emitting device.

[0414] The method of synthesizing the organometallic compound represented by Formula 1 may be apparent to one of ordinary skill in the art by referring to the synthesis examples provided herein.

[0415] The organometallic compound represented by Formula 1 may be suitable for use in an organic layer of an organic light-emitting device, for example, as an emission layer material in the organic layer. Therefore, according to another aspect, an organic light-emitting device is provided, which may include: a first electrode; a second electrode; and an organic layer disposed between the first electrode and the second electrode and including an emission layer; wherein the organic layer may include at least one organometallic compound represented by Formula 1.

[0416] The organic light emitting device may include an organic layer including the organic metal compound represented by Formula 1. Therefore, the organic light emitting device may have excellent driving voltage, excellent external quantum efficiency, a relatively small full width at half maximum (FWHM) of an emission peak in an electroluminescence (EL) spectrum, and excellent lifespan characteristics.

[0417] The organic metal compound represented by Formula 1 can be used between the electrode pairs of the organic light-emitting device. For example, the organic metal compound represented by Formula 1 can be included in the emission layer. In some embodiments, the emission layer can further include a host. In some embodiments, the content of the host can be greater than the content of the organic metal compound. The emission layer can emit red light, green light, or blue light. In some embodiments, the organic metal compound can emit blue light.

[0418] In some embodiments, the emission layer may be the first embodiment or the second embodiment.

[0419] First embodiment

[0420] The emission layer may include an organic metal compound represented by Formula 1, and the organic metal compound may be used as a phosphorescent emitter. For example, the ratio of the emission component emitted from the organic metal compound may be 80 percent (%) or more, 85% or more, 90% or more, or 95% or more of the total emission component emitted from the emission layer. Blue light may be emitted from the organic metal compound.

[0421] Second embodiment

[0422] In addition to the organic metal compound represented by Formula 1, the emission layer may further include a phosphorescent dopant, a fluorescent dopant, or any combination thereof that is different from the organic metal compound. Here, the organic metal compound may not be used as a phosphorescent emitter, but as a sensitizer or an auxiliary dopant. In some embodiments, the emission layer may further include a fluorescent dopant, which may be different from the organic metal compound, and the ratio of the emission component emitted from the fluorescent dopant may be 80% or more, 85% or more, 90% or more, or 95% or more of the total emission component emitted from the emission layer.

[0423] In the second embodiment, the fluorescent dopant may be included in an amount ranging from about 1 to about 100 parts by weight, from about 5 to about 50 parts by weight, or from about 10 to about 20 parts by weight based on 100 parts by weight of the organic metal compound represented by Formula 1.

[0424] In a second embodiment, the total content of the organic metal compound represented by Formula 1 and the fluorescent dopant may be in a range of about 1 part by weight to about 30 parts by weight, about 3 parts by weight to about 20 parts by weight, or about 5 parts by weight to about 15 parts by weight based on 100 parts by weight of the emission layer.

[0425] The fluorescent dopant that can be used in the second embodiment may not include a transition metal.

[0426] In some embodiments, the fluorescent dopant that may be used in the second embodiment may be a fluorescent emitting material that does not include a cyano group (—CN) and a fluorine group (—F).

[0427] In some embodiments, the fluorescent dopant that can be used in the second embodiment may be a compound including a condensed ring, a compound including an amino group, a compound including a styryl group, or a compound including a boron group.

[0428] In some embodiments, the fluorescent dopant that may be used in the second embodiment may include a compound including an amino group.

[0429] In some embodiments, the fluorescent dopant that can be used in the second embodiment may include a naphthyl group, a fluorene group, a spiro-bifluorene group, a benzofluorene group, a dibenzofluorene group, a phenanthrene group, an anthracene group, a fluoranthene group, a benzo[9,10]phenanthrene group, a pyrene group, Group, tetraphenyl group (tetraphenyl group), Group, A group, a pentaphene group, an indenoanthracene group, a group represented by one of Formulae 501-1 to 501-21, or any combination thereof:

[0430]

[0431]

[0432] In one or more embodiments, the fluorescent dopant that can be used in the second embodiment may include a compound represented by Formula 501A or 501B:

[0433]

[0434] Wherein, in Formulas 501A and 501B,

[0435] Ar 501 It can be a naphthyl group, a fluorene group, a spiro-bifluorene group, a benzofluorene group, a dibenzofluorene group, a phenanthrene group, an anthracene group, a fluoranthene group, a benzo[9,10]phenanthrene group, a pyrene group, Group, tetraphenyl group, Group, group, a pentaphene group, an indenoanthracene group, a bianthracene group, or a group represented by one of Formulae 501-1 to 501-21,

[0436] R 511 It may be hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl, nitro, amino, amidine, hydrazine, hydrazone, carboxylic acid or its salt, sulfonic acid or its salt, phosphoric acid or its salt, C 1 -C 60 Alkyl, C 2 -C 60 Alkenyl, C 2 -C 60 Alkynyl, C 1 -C 60 Alkoxy, C 3 -C 10 Cycloalkyl, C 1 -C 10 Heterocycloalkyl, C 3 -C 10 Cycloalkenyl, C 2 -C 10 Heterocycloalkenyl, unsaturated C 1 -C10 Heterocyclic group, C 6 -C 60 Aryl, C 6 -C 60 Aryloxy, C 6 -C 60 Arylthio, C 1 -C 60 heteroaryl, a monovalent non-aromatic fused polycyclic group, a monovalent non-aromatic fused heteropolycyclic group, or -Si(Q 501 )(Q 502 )(Q 503 ),

[0437] xd5 can be an integer from 0 to 10.

[0438] L 501 -L 503 Can be independently:

[0439] Single bond; and

[0440] Each C is unsubstituted or substituted as follows 3 -C 10 Cycloalkylene, C 1 -C 10 Heterocycloalkylene, C 3 -C 10 Cycloalkenylene, C 2 -C 10 Heterocycloalkenylene, unsaturated C 1 -C 10 Heterocyclic group, C 6 -C 60 Arylene, C 1 -C 60 heteroarylene group, a divalent non-aromatic condensed polycyclic group, or a divalent non-aromatic condensed heteropolycyclic group: deuterium, -F, -Cl, -Br, -I, hydroxyl, nitro, amino, amidino, hydrazine, hydrazone, carboxylic acid group or its salt, sulfonic acid group or its salt, phosphoric acid group or its salt, C 1 -C 60 Alkyl, C 2 -C 60 Alkenyl, C 2 -C 60 Alkynyl, C 1 -C 60 Alkoxy, C 3 -C 10 Cycloalkyl, C 1 -C 10 Heterocycloalkyl, C 3 -C 10 Cycloalkenyl, C 2 -C 10 Heterocycloalkenyl, unsaturated C 1-C 10 Heterocyclic group, C 6 -C 60 Aryl, C 6 -C 60 Aryloxy, C 6 -C 60 Arylthio, C 1 -C 60 heteroaryl, monovalent non-aromatic fused polycyclic group, monovalent non-aromatic fused heteropolycyclic group, -Si(Q 501 )(Q 502 )(Q 503 ), or any combination thereof,

[0441] xd1-xd3 can each independently be 1, 2, or 3,

[0442] R 501 and R 502 may be each independently unsubstituted or substituted by phenyl, naphthyl, fluorenyl, spiro-bifluorenyl, benzofluorenyl, dibenzofluorenyl, phenanthryl, anthracenyl, pyrenyl, yl, pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, quinolyl, isoquinolyl, quinoxalinyl, quinazolinyl, carbazolyl, triazinyl, dibenzofuranyl, dibenzothiophenyl, or dibenzosilyl: deuterium, -F, -Cl, -Br, -I, hydroxyl, nitro, amino, amidino, hydrazine, hydrazone, carboxylic acid group or its salt, sulfonic acid group or its salt, phosphoric acid group or its salt, C 1 -C 60 Alkyl, C 2 -C 60 Alkenyl, C 2 -C 60 Alkynyl, C 1 -C 60 Alkoxy, C 3 -C 10 Cycloalkyl, C 1 -C 10 Heterocycloalkyl, C 3 -C 10 Cycloalkenyl, C 2 -C 10 Heterocycloalkenyl, unsaturated C 1 -C 10 Heterocyclic group, C 6 -C 60 Aryl, C 6 -C 60 Aryloxy, C 6 -C 60 Arylthio, C 1 -C 60 heteroaryl, monovalent non-aromatic fused polycyclic group, monovalent non-aromatic fused heteropolycyclic group, -Si(Q501 )(Q 502 )(Q 503 ), or any combination thereof,

[0443] Z 11 may be C each unsubstituted or substituted as follows 1 -C 60 Alkyl, C 2 -C 60 Alkenyl, C 2 -C 60 Alkynyl, C 1 -C 60 Alkoxy, C 3 -C 10 Cycloalkyl, C 1 -C 10 Heterocycloalkyl, C 3 -C 10 Cycloalkenyl, C 2 -C 10 Heterocycloalkenyl, unsaturated C 1 -C 10 Heterocyclic group, C 6 -C 60 Aryl, C 6 -C 60 Aryloxy, C 6 -C 60 Arylthio, C 1 -C 60 heteroaryl, monovalent non-aromatic condensed polycyclic group, or monovalent non-aromatic condensed heteropolycyclic group: deuterium, -F, -Cl, -Br, -I, hydroxyl, nitro, amino, amidino, hydrazine, hydrazone, carboxylic acid group or its salt, sulfonic acid group or its salt, phosphoric acid group or its salt, C 1 -C 60 Alkyl, C 2 -C 60 Alkenyl, C 2 -C 60 Alkynyl, C 1 -C 60 Alkoxy, C 3 -C 10 Cycloalkyl, C 1 -C 10 Heterocycloalkyl, C 3 -C 10 Cycloalkenyl, C 2 -C 10 Heterocycloalkenyl, unsaturated C 1 -C 10 Heterocyclic group, C 6 -C 60 Aryl, C 6 -C 60 Aryloxy, C 6-C 60 Arylthio, C 1 -C 60 heteroaryl, monovalent non-aromatic fused polycyclic group, monovalent non-aromatic fused heteropolycyclic group, -Si(Q 501 )(Q 502 )(Q 503 ), or any combination thereof,

[0444] xd4 can be 1, 2, 3, 4, 5, or 6, and

[0445] Where Q 501 -Q 503 can be independently hydrogen, C 1 -C 60 Alkyl, C 1 -C 60 Alkoxy, C 6 -C 60 Aryl, C 1 -C 60 a heteroaryl group, a monovalent non-aromatic fused polycyclic group, or a monovalent non-aromatic fused heteropolycyclic group.

[0446] In one or more embodiments, the fluorescent dopant may include a compound represented by Formula 501A or 501B, where xd4 in Formula 501A may be 1, 2, 3, 4, 5, or 6, and xd4 in Formula 501B may be 2, 3, or 4.

[0447] In one or more embodiments, the fluorescent dopant may include one of compounds FD(1) to FD(16), one of compounds FD1 to FD16, or any combination thereof:

[0448]

[0449]

[0450]

[0451] As used herein, the expression “(the organic layer) includes at least one organometallic compound represented by Formula 1” may be interpreted to mean “(the organic layer) may include one organometallic compound of Formula 1 or two or more different organometallic compounds of Formula 1”.

[0452] For example, only Compound 1 may be included in the organic layer as an organometallic compound. In this embodiment, Compound 1 may be included in the emission layer of the organic light-emitting device. In some embodiments, Compounds 1 and 2 may be included in the organic layer as organometallic compounds. In this embodiment, Compounds 1 and 2 may both be included in the same layer (for example, Compounds 1 and 2 may both be included in the emission layer).

[0453] The first electrode may be an anode as a hole injection electrode, and the second electrode may be a cathode as an electron injection electrode. In some embodiments, the first electrode may be a cathode as an electron injection electrode, and the second electrode may be an anode as a hole injection electrode.

[0454] For example, in the organic light-emitting device, the first electrode may be an anode, the second electrode may be a cathode, and the organic layer may further include a hole transport region disposed between the first electrode and the emission layer and an electron transport region disposed between the emission layer and the second electrode, wherein the hole transport region may include a hole injection layer, a hole transport layer, an electron blocking layer, a buffer layer, or a combination thereof, and the electron transport region may include a hole blocking layer, an electron transport layer, an electron injection layer, or a combination thereof.

[0455] The term "organic layer" as used herein refers to a single layer and / or a plurality of layers disposed between a first electrode and a second electrode in an organic light emitting device. The "organic layer" may include not only an organic compound but also an organic metal complex including a metal.

[0456] Figure 1 1 is a schematic cross-sectional view of an organic light emitting device 10 according to an exemplary embodiment. Figure 1 The structure of an organic light emitting device and a method of manufacturing the same according to one or more embodiments are described. The organic light emitting device 10 may include a first electrode 11, an organic layer 15, and a second electrode 19, which may be sequentially stacked in the order of the statements.

[0457] A substrate may be additionally provided under the first electrode 11 or on the second electrode 19. The substrate may be a conventional substrate used in an organic light emitting device, such as a glass substrate or a transparent plastic substrate each having excellent mechanical strength, thermal stability, transparency, surface smoothness, ease of handling, and water resistance.

[0458] The first electrode 11 may be formed by depositing or sputtering a material for forming the first electrode 11 onto the substrate. The first electrode 11 may be an anode. The material for forming the first electrode 11 may include a material having a high work function for easy hole injection. The first electrode 11 may be a reflective electrode, a semi-transmissive electrode, or a transmissive electrode. The material for forming the first electrode 11 may be indium tin oxide (ITO), indium zinc oxide (IZO), tin oxide (SnO 2 ), and zinc oxide (ZnO). In some embodiments, the material used to form the first electrode 11 may be a metal such as magnesium (Mg), aluminum (Al), aluminum-lithium (Al-Li), calcium (Ca), magnesium-indium (Mg-In), or magnesium-silver (Mg-Ag).

[0459] The first electrode 11 may have a single-layer structure or a multi-layer structure including a plurality of layers. In some embodiments, the first electrode 11 may have a triple-layer structure of ITO / Ag / ITO.

[0460] The organic layer 15 may be on the first electrode 11 .

[0461] The organic layer 15 may include a hole transport region, an emission layer, and an electron transport region.

[0462] The hole transport region may be between the first electrode 11 and the emission layer.

[0463] The hole transport region may include a hole injection layer, a hole transport layer, an electron blocking layer, a buffer layer, or a combination thereof.

[0464] The hole transport region may include only a hole injection layer or only a hole transport layer. In some embodiments, the hole transport region may include a hole injection layer and a hole transport layer sequentially stacked on the first electrode 11. In some embodiments, the hole transport region may include a hole injection layer, a hole transport layer, and an electron blocking layer sequentially stacked on the first electrode 11.

[0465] When the hole transport region includes a hole injection layer, the hole injection layer may be formed on the first electrode 11 by using one or more suitable methods such as vacuum deposition, spin coating, casting, or Langmuir-Blodgett (LB) deposition.

[0466] When the hole injection layer is formed by vacuum deposition, for example, the vacuum deposition may be performed at a deposition temperature in a range of about 100° C. to about 500° C., at a temperature of about 10 -8 Torr - about 10 -3 Torr range, and at about 0.01 angstrom / second ( / second)-approx. The conditions for the vacuum deposition are performed at a deposition rate in the range of 100 Å / sec, and although the conditions may vary depending on the compound used as the hole injection material and the structure and thermal properties of the desired hole injection layer, the conditions for the vacuum deposition are not limited thereto.

[0467] When the hole injection layer is formed by spin coating, the spin coating may be performed at a coating rate in the range of about 2,000 revolutions per minute (rpm) to about 5,000 rpm and at a temperature in the range of about 80° C. to about 200° C. to facilitate removal of the solvent after spin coating, although the conditions may vary depending on the compound used as the hole injection material and the desired structure and thermal properties of the hole injection layer, but the conditions for the spin coating are not limited thereto.

[0468] The conditions for forming the hole transport layer and the electron blocking layer can be inferred from the conditions for forming the hole injection layer.

[0469] The hole transport region may include m-MTDATA, TDATA, 2-TNATA, NPB, β-NPB, TPD, spiro-TPD, spiro-NPB, methylated NPB, TAPC, HMTPD, 4,4',4"-tri(N-carbazolyl)triphenylamine (TCTA), polyaniline / dodecylbenzenesulfonic acid (PANI / DBSA), poly(3,4-ethylenedioxythiophene) / poly(4-styrenesulfonate) (PEDOT / PSS), polyaniline / camphorsulfonic acid (PANI / CSA), polyaniline / poly(4-styrenesulfonate) (PANI / PSS), a compound represented by Formula 201, a compound represented by Formula 202, or any combination thereof:

[0470]

[0471] Formula 201

[0472]

[0473] Formula 202

[0474]

[0475] Wherein, in formula 201, Ar 101 and Ar 102 may be each independently unsubstituted or substituted by phenylene, pentalene, indenylene, naphthylene, 1,1-diyl ... phenylene, tetraphenylene, Base, Asia , or pentacene: deuterium, -F, -Cl, -Br, -I, hydroxyl, cyano, nitro, amino, amidino, hydrazine, hydrazone, carboxylic acid group or its salt, sulfonic acid group or its salt, phosphoric acid group or its salt, C 1 -C 60 Alkyl, C 2 -C 60 Alkenyl, C 2 -C 60 Alkynyl, C 1 -C 60 Alkoxy, C 3 -C 10 Cycloalkyl, C 3 -C 10 Cycloalkenyl, C 1 -C 10 Heterocycloalkyl, C 2 -C 10 Heterocycloalkenyl, unsaturated C 1 -C 10 Heterocyclic group, C 6 -C 60 Aryl, C 6 -C 60 Aryloxy, C 6 -C 60 Arylthio, C 1 -C 60 a heteroaryl group, a monovalent non-aromatic fused polycyclic group, a monovalent non-aromatic fused heteropolycyclic group, or any combination thereof.

[0476] In Formula 201, xa and xb may each independently be an integer from 0 to 5. In some embodiments, xa and xb may each independently be an integer from 0 to 2. In some embodiments, xa may be 1, and xb may be 0, but the embodiments are not limited thereto.

[0477] In equations 201 and 202, R 101 -R 108 , R 111 -R 119 , and R 121 -R 124 Can be independently:

[0478] hydrogen, deuterium, -F, -Cl, -Br, -I, hydroxyl, cyano, nitro, amino, amidino, hydrazine, hydrazone, carboxylic acid group or its salt, sulfonic acid group or its salt, phosphoric acid group or its salt, C 1 -C 10 Alkyl (e.g., methyl, ethyl, propyl, butyl, pentyl, or hexyl), or C 1 -C 10 Alkoxy (e.g., methoxy, ethoxy, propoxy, butoxy, or pentoxy);

[0479] Each unsubstituted and substituted C 1 -C 10 Alkyl or C 1 -C 10 Alkoxy: deuterium, -F, -Cl, -Br, -I, hydroxyl, cyano, nitro, amino, amidino, hydrazine, hydrazone, carboxylic acid group or its salt, sulfonic acid group or its salt, phosphoric acid group or its salt, or any combination thereof; or

[0480] phenyl, naphthyl, anthracenyl, fluorenyl, or pyrenyl, each unsubstituted or substituted with: deuterium, -F, -Cl, -Br, -I, hydroxyl, cyano, nitro, amino, amidino, hydrazine, hydrazone, carboxylic acid or salt thereof, sulfonic acid or salt thereof, phosphoric acid or salt thereof, C 1 -C 10 Alkyl, C 1 -C 10 alkoxy, or any combination thereof.

[0481] In formula 201, R 109 The phenyl, naphthyl, anthracenyl, or pyridyl groups may be unsubstituted or substituted by deuterium, -F, -Cl, -Br, -I, hydroxyl, cyano, nitro, amino, amidino, hydrazine, hydrazone, carboxylic acid or salts thereof, sulfonic acid or salts thereof, phosphoric acid or salts thereof, C 1 -C 20 Alkyl, C 1 -C 20 alkoxy, phenyl, naphthyl, anthracenyl, pyridyl, or any combination thereof.

[0482] In some embodiments, the compound represented by Formula 201 can be represented by Formula 201A:

[0483] Formula 201A

[0484]

[0485] Wherein, in Formula 201A, R 101 , R 111 , R 112 , and R 109 can be respectively referred to the R provided in this article 101 , R 111 , R 112 , and R 109 Description understanding.

[0486] In some embodiments, the hole transport region may include one or any combination of compounds HT1 to HT20:

[0487]

[0488]

[0489] The thickness of the hole transport region may be about 100 (angstroms). -about and in some embodiments about -about When the hole transport region includes a hole injection layer, a hole transport layer, or a combination thereof, the thickness of the hole injection layer may be about -about and in some embodiments about -about In the range of, and the thickness of the hole transport layer may be about -about and in some embodiments about -about When the thicknesses of the hole transport region, the hole injection layer, and the hole transport layer are within any of these ranges, excellent hole transport characteristics may be obtained without a significant increase in driving voltage.

[0490] In addition to the above materials, the hole transport region may further include a charge generating material to improve the conductive properties of the hole transport region. The charge generating material may be substantially uniformly or non-uniformly dispersed in the hole transport region.

[0491] The charge generating material may include, for example, a p-dopant. The p-dopant may be a quinone derivative, a metal oxide, a compound containing a cyano group, or any combination thereof, but the embodiment is not limited thereto. In some embodiments, the p-dopant may be a quinone derivative such as tetracyanoquinodimethane (TCNQ), 2,3,5,6-tetrafluoro-tetracyano-1,4-benzoquinodimethane (F4-TCNQ), or F6-TCNNQ; a metal oxide such as tungsten oxide or molybdenum oxide; a compound containing a cyano group such as compound HT-D1; or any combination thereof:

[0492]

[0493] The hole transport region may further include a buffer layer.

[0494] The buffer layer may compensate for an optical resonance distance depending on a wavelength of light emitted from the emission layer to improve efficiency of an organic light emitting device.

[0495] When the hole transport region includes an electron blocking layer, the material used to form the electron blocking layer may include the material used to form the hole transport region, the host material described herein, or any combination thereof. In some embodiments, when the hole transport region includes an electron blocking layer, the mCP described herein, etc. may be used to form the electron blocking layer.

[0496] The emission layer may be formed on the hole transport region by using one or more suitable methods such as vacuum deposition, spin coating, casting, or LB deposition. When the emission layer is formed by vacuum deposition or spin coating, the vacuum deposition and coating conditions for forming the emission layer may be substantially similar to those for forming the hole injection layer, although the conditions may vary depending on the compound used.

[0497] The emission layer may include a host and a dopant, and the dopant may include an organic metal compound represented by Formula 1 described herein.

[0498] The host may include TPBi, TBADN, ADN (also referred to as "DNA"), CBP, CDBP, TCP, mCP, Compound H50, Compound H51, Compound H52, or any combination thereof:

[0499] When the organic light emitting device 10 is a full-color organic light emitting device, the emission layer may be patterned into a red emission layer, a green emission layer, and / or a blue emission layer. In some embodiments, the emission layer may have a structure in which a red emission layer, a green emission layer, and / or a blue emission layer are stacked to emit white light. In some embodiments, the structure of the emission layer may be changed.

[0500] When the emission layer includes a host and a dopant, an amount of the dopant may be in a range of about 0.01 parts by weight to about 15 parts by weight based on about 100 parts by weight of the host, but embodiments are not limited thereto.

[0501] The thickness of the emission layer may be about -about and in some embodiments about -about When the thickness of the emission layer is within any of these ranges, improved light emitting characteristics may be obtained without a significant increase in driving voltage.

[0502] Next, an electron transport region may be formed on the emission layer.

[0503] The electron transport region may include a hole blocking layer, an electron transport layer, an electron injection layer, or a combination thereof.

[0504] In some embodiments, the electron transport region may have a hole blocking layer / electron transport layer / electron injection layer structure or an electron transport layer / electron injection layer structure, but the embodiment is not limited thereto. The electron transport layer may have a multilayer structure or a single layer structure including two or more different materials.

[0505] Based on the conditions for forming the hole injection layer, the conditions for forming the hole blocking layer, the electron transport layer, and the electron injection layer can be inferred.

[0506] When the electron transport region includes a hole blocking layer, the hole blocking layer may include, for example, at least one of BCP, Bphen, and BAlq:

[0507]

[0508] In some embodiments, the hole blocking layer may include the host, a material described herein for forming an electron transport layer, a material described herein for an electron injection layer, or any combination thereof.

[0509] The thickness of the hole blocking layer may be about -about and in some embodiments about -about When the thickness of the hole blocking layer is within any of these ranges, excellent hole blocking characteristics may be obtained without a significant increase in driving voltage.

[0510] The electron transport layer may include BCP, Bphen, TPBi, Alq 3 , BAlq, TAZ, NTAZ, or any combination thereof:

[0511]

[0512]

[0513]

[0514] The thickness of the electron transport layer may be about -about and in some embodiments about -about When the thickness of the electron transport layer is within any of these ranges, excellent electron transport characteristics may be obtained without a significant increase in driving voltage.

[0515] The electron transport layer may further include a material including a metal in addition to the materials described above.

[0516] The metal-containing material may include a Li complex. The Li complex may include, for example, compound ET-D1 or compound ET-D2:

[0517]

[0518] The electron transport region may include an electron injection layer that facilitates electron injection from the second electrode 19 .

[0519] The electron injection layer may include LiF, NaCl, CsF, Li 2 O, BaO, or any combination thereof.

[0520] The thickness of the electron injection layer can be about -about For example, about -about When the thickness of the electron injection layer is within any of these ranges, excellent electron injection characteristics may be obtained without a significant increase in driving voltage.

[0521] The second electrode 19 may be on the organic layer 15. The second electrode 19 may be a cathode. The material used to form the second electrode 19 may be a material having a relatively low work function such as a metal, an alloy, a conductive compound, or any combination thereof. Examples of materials used to form the second electrode 19 may include lithium (Li), magnesium (Mg), aluminum (Al), aluminum-lithium (Al-Li), calcium (Ca), magnesium-indium (Mg-In), and magnesium-silver (Mg-Ag). In some embodiments, ITO or IZO may be used to form a transmissive second electrode 19 to manufacture a top-emitting light-emitting device. In some embodiments, the material used to form the second electrode 19 may be changed.

[0522] In the previous article, reference has been made to Figure 1 The organic light emitting device 10 is described, but the embodiment is not limited thereto.

[0523] According to another aspect, the organic light emitting device may be included in an electronic device. Therefore, another aspect of the present disclosure provides an electronic device including the organic light emitting device. The electronic device may include, for example, a display, a lighting device, a sensor, etc.

[0524] According to aspects of yet another embodiment, the diagnostic composition may include at least one organometallic compound represented by Formula 1.

[0525] Since the organometallic compound represented by Formula 1 provides high luminescence efficiency, the diagnostic efficiency of the diagnostic composition including the organometallic compound represented by Formula 1 may be excellent.

[0526] The diagnostic composition can be used in various ways, for example, in a diagnostic kit, a diagnostic reagent, a biosensor, or a biomarker.

[0527] All radicals and compounds are understood to include all possible isomers, including structural isomers, that occur in said radicals or compounds. Structural isomers differ from one another in the connection of the constituent atoms. As a general example, and without limitation, The structural isomers of oxadiazole include 1,2,3- Oxadiazole, 1,2,4- Oxadiazole, 1,2,5- Oxadiazole, and 1,3,4- Oxadiazole.

[0528] As used herein, the term "C 1 -C 60 "Alkyl" refers to a straight chain or branched saturated aliphatic hydrocarbon monovalent group having 1 to 60 carbon atoms. As used herein, the term "C 1 -C 60 "Alkylene" refers to a group having a C 1 -C 60 Alkyl is a divalent group of the same structure.

[0529] As used in this article, C 1 -C 60 Alkyl, C 1 -C 20 Alkyl, and / or C 1 -C 10 Examples of the alkyl group may include methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl, tert-pentyl, neopentyl, isopentyl, sec-pentyl, 3-pentyl, sec-isopentyl, n-hexyl, isohexyl, sec-hexyl, tert-hexyl, n-heptyl, isoheptyl, sec-heptyl, tert-heptyl, n-octyl, isooctyl, sec-octyl, tert-octyl, n-nonyl, isononyl, sec-nonyl, tert-nonyl, n-decyl, isodecyl, sec- Decyl, or tert-decyl: methyl, ethyl, n-propyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, n-pentyl, tert-pentyl, neopentyl, isopentyl, sec-pentyl, 3-pentyl, sec-isopentyl, n-hexyl, isohexyl, sec-hexyl, tert-hexyl, n-heptyl, isoheptyl, sec-heptyl, tert-heptyl, n-octyl, isooctyl, sec-octyl, tert-octyl, n-nonyl, isononyl, sec-nonyl, tert-nonyl, n-decyl, isodecyl, sec-decyl, tert-decyl, or any combination thereof. In some embodiments, Formula 9-33 may be a branched C 6 Formula 9-33 may be a tert-butyl group substituted with two methyl groups.

[0530] As used herein, the term "C 1 -C 60 "Alkoxy" refers to a 101 (A 101 C 1 -C60 A monovalent group represented by an alkyl group.

[0531] As used in this article, C 1 -C 60 Alkoxy, C 1 -C 20 Alkoxy, or C 1 -C 10 Examples of the alkoxy group may include a methoxy group, an ethoxy group, a propoxy group, a butoxy group, or a pentoxy group.

[0532] As used herein, the term "C 2 -C 60 "Alkenyl" refers to a group consisting of 2 -C 60 A group formed by placing at least one carbon-carbon double bond in the middle or at the end of an alkyl group. Examples thereof include ethenyl, propenyl, and butenyl. As used herein, the term "C 2 -C 60 "Alkenylene" refers to a 2 -C 60 Alkenyl is a divalent group of the same structure.

[0533] As used herein, the term "C 2 -C 60 "Alkynyl" refers to a 2 -C 60 A group formed by placing at least one carbon-carbon triple bond in the middle or at the end of an alkyl group. Examples thereof include ethynyl and propynyl. As used herein, the term “C 2 -C 60 "Alkyne" refers to a group having a C 2 -C 60 Alkynyl is a divalent group of the same structure.

[0534] As used herein, the term "C 3 -C 10 "Cycloalkyl" refers to a monovalent cyclic saturated hydrocarbon group comprising 3 to 10 carbon atoms. As used herein, the term "C 3 -C 10 "Cycloalkylene" refers to a cycloalkylene having a 3 -C 10 Cycloalkyl is a divalent group of the same structure.

[0535] As used in this article, C 3 -C 10 Examples of cycloalkyl groups may include cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, adamantyl, bicyclo[1.1.1]pentyl, bicyclo[2.1.1]hexyl, bicyclo[2.2.1]heptyl (norbornyl), or bicyclo[2.2.2]octyl.

[0536] As used herein, the term "C 1 -C 10 "Heterocycloalkyl" refers to a monovalent monocyclic group including at least one N, O, P, Si, B, Se, Ge, S, or any combination thereof as a ring atom and 1 to 10 carbon atoms. As used herein, the term "C 1 -C 10 "Heterocycloalkylene" refers to a group having a C 1 -C 10 Heterocycloalkyl is a divalent group of the same structure.

[0537] As used in this article, C 1 -C 10 Examples of the heterocycloalkyl group may include a silacyclopentyl group, a silacyclohexyl group, a tetrahydrofuranyl group, a tetrahydro-2H-pyranyl group, or a tetrahydrothienyl group.

[0538] As used herein, the term "C 3 -C 10 "Cycloalkenyl" refers to a monovalent monocyclic group having 3 to 10 carbon atoms and at least one carbon-carbon double bond in its ring, wherein the molecular structure as a whole is non-aromatic. Examples thereof include cyclopentenyl, cyclohexenyl, and cycloheptenyl. As used herein, the term "C 3 -C 10 "Cycloalkenylene" refers to a 3 -C 10 Cycloalkenyl is a divalent group of the same structure.

[0539] As used herein, the term "C 2 -C 10 "Heterocycloalkenyl" refers to a monovalent monocyclic group including at least one N, O, P, Si, B, Se, Ge, S, or any combination thereof as a ring atom, 2 to 10 carbon atoms, and at least one carbon-carbon double bond in its ring. 2 -C 10 Examples of heterocycloalkenyl groups include 2,3-dihydrofuranyl and 2,3-dihydrothienyl. 2 -C 10 "Heterocycloalkenylene" refers to a 2 -C 10 Heterocycloalkenyl is a divalent group of the same structure.

[0540] As used herein, the term "unsaturated C 1 -C 10The term "heterocyclic group" refers to a monovalent monocyclic group that includes at least one N, O, P, Si, B, Se, Ge, S, or any combination thereof as a ring atom, 1 to 10 carbon atoms, and at least one heteroatom-carbon double bond, heteroatom-heteroatom double bond, or a combination thereof in its ring. Unsaturated C 1 -C 10 Examples of heterocyclic groups include oxazine and imidazoline.

[0541] As used herein, the term "C 6 -C 60 "Aryl" refers to a monovalent group having a carbocyclic aromatic system having 6 to 60 carbon atoms. As used herein, the term "C 6 -C 60 "Arylene" refers to a divalent group having a carbocyclic aromatic system having 6 to 60 carbon atoms. 6 -C 60 Examples of aryl groups include phenyl, naphthyl, anthracenyl, phenanthrenyl, pyrenyl, and When C 6 -C 60 Aryl and C 6 -C 60 When the arylene groups each include a plurality of rings, the plurality of rings may be fused to each other.

[0542] As used herein, the term "C 7 -C 60 "Alkaryl" refers to a 1 -C 54 Alkyl substituted C 6 -C 59 Aryl.

[0543] As used herein, the term "C 1 -C 60 "Heteroaryl" refers to a monovalent group having a heterocyclic aromatic system having at least one N, O, P, Si, B, Se, Ge, S, or any combination thereof as a ring atom and 1 to 60 carbon atoms. As used herein, the term "C 1 -C 60 The term "heteroarylene" refers to a divalent group having a heterocyclic aromatic system having at least one N, O, P, Si, B, Se, Ge, S, or any combination thereof as a ring atom and 1 to 60 carbon atoms. 1 -C 60 Examples of heteroaryl groups include pyridyl, pyrimidinyl, pyrazinyl, pyridazinyl, triazinyl, quinolyl, and isoquinolyl. 1 -C 60 Heteroaryl and C 1 -C60 When the heteroarylene groups each include a plurality of rings, the plurality of rings may be fused to each other.

[0544] As used herein, the term "C 2 -C 60 "Alkylheteroaryl" refers to a 1 -C 59 Alkyl substituted C 1 -C 59 Heteroaryl.

[0545] As used herein, the term "C 6 -C 60 Aryloxy" is represented by -OA 102 (A 102 C 6 -C 60 As used herein, the term "C 6 -C 60 Arylthio" is represented by -SA 103 (A 103 C 6 -C 60 As used herein, the term "C 1 -C 60 "Alkylthio" is represented by -SA 104 (A 104 C 1 -C 60 Alkyl) represents.

[0546] The term "monovalent non-aromatic fused polycyclic group" as used herein refers to a monovalent group having two or more fused rings and having only carbon atoms (e.g., the number of carbon atoms may be in the range of 8-60) as ring-forming atoms, wherein the molecular structure as a whole is non-aromatic. Examples of monovalent non-aromatic fused polycyclic groups include fluorenyl. The term "divalent non-aromatic fused polycyclic group" as used herein refers to a divalent group having a structure substantially the same as that of a monovalent non-aromatic fused polycyclic group.

[0547] The term "monovalent non-aromatic fused heteropolycyclic group" as used herein refers to a monovalent group having two or more fused rings and having at least one N, O, P, Si, B, Se, Ge, S, or any combination thereof and a carbon atom (e.g., the number of carbon atoms may be in the range of 1-60) as a ring-forming atom, wherein the molecular structure as a whole is non-aromatic. Examples of monovalent non-aromatic fused heteropolycyclic groups include carbazolyl. The term "divalent non-aromatic fused heteropolycyclic group" as used herein refers to a divalent group having a structure substantially the same as a monovalent non-aromatic fused heteropolycyclic group.

[0548] As used herein, the term "C5 -C 30 The term "carbocyclic group" refers to a saturated or unsaturated cyclic group containing only 5 to 30 carbon atoms as ring atoms. 5 -C 30 The carbocyclic group may be a monocyclic group or a polycyclic group. 10a Replaced by)C 5 -C 30 Examples of the "carbocyclic group" may include (each unsubstituted or substituted by at least one R 10a substituted) adamantane group, norbornene group, bicyclo[1.1.1]pentane group, bicyclo[2.1.1]hexane group, bicyclo[2.2.1]heptane group (norbornene group), bicyclo[2.2.2]octane group, cyclopentane group, cyclohexane group, cyclohexene group, phenyl group, naphthalene group, anthracene group, phenanthrene group, benzo[9,10]phenanthrene group, pyrene group, group, a 1,2,3,4-tetrahydronaphthalene group, a cyclopentadiene group, or a fluorene group.

[0549] As used herein, the term "C 1 -C 30 The term "heterocyclic group" refers to a saturated or unsaturated cyclic group comprising 1 to 30 carbon atoms and at least one N, O, P, Si, B, Se, Ge, S, or any combination thereof as a ring atom. 1 -C 30 The heterocyclic group may be a monocyclic group or a polycyclic group. 10a Replaced by)C 1 -C 30 Examples of the "heterocyclic group" may include each of which is unsubstituted or substituted with at least one R 10asubstituted) thiophene group, furan group, pyrrole group, thiol group, borolide group, phospholide group, selenophene group, germanol group, benzothiophene group, benzofuran group, indole group, benzothiol group, benzoborol group, benzophospholide group, benzoselenophene group, benzogermanol group, dibenzothiophene group, dibenzofuran group, carbazole group, dibenzofuran group, benzothiole group, dibenzoborole group, dibenzophosphole group, dibenzoselenophene group, dibenzogermanol group, dibenzothiophene 5-oxide group, 9H-fluoren-9-one group, dibenzothiophene 5,5-dioxide group, azabenzothiophene group, azabenzofuran group, azaindole group, azaindene group, azabenzothiole group, azabenzoborole group, azabenzothiophene ... heterobenzophosphoside group, azabenzoselenophene group, azabenzogermanoside group, azadibenzothiophene group, azadibenzofuran group, azacarbazole group, azafluorene group, azadibenzothiole group, azadibenzoborole group, azadibenzophosphoside group, azadibenzoselenophene group, azadibenzogermanoside group, azadibenzothiophene 5-oxide group, nitrogen hetero-9H-fluoren-9-one group, azadibenzothiophene 5,5-dioxide group, pyridine group, pyrimidine group, pyrazine group, pyridazine group, 1,3,5-triazine group, 1,2,3-triazine group, 1,2,4-triazine group, quinoline group, isoquinoline group, quinoxaline group, quinazoline group, phenanthroline group, pyrazole group, imidazole group, 1,2,3-triazole group, 1,2,4-triazole group, Azole group, iso azole group, thiazole group, isothiazole group, oxadiazole group, thiadiazole group, benzopyrazole group, benzimidazole group, benzo Azole group, benzothiazole group, benzo a oxadiazole group, a benzothiadiazole group, a 5,6,7,8-tetrahydroisoquinoline group, or a 5,6,7,8-tetrahydroquinoline group.

[0550] As used herein, "deuterated C 1 -C 60 Alkyl (or deuterated C 1 -C 20 Alkyl, etc.)", "deuterated C 3 -C 10 Cycloalkyl", "deuterated C 1 -C 10 "Heterocycloalkyl" and "deuterated phenyl" may be C 1 -C 60 Alkyl (or C 1 -C20 Alkyl, etc.), C 3 -C 10 Cycloalkyl, C 1 -C 10 Heterocycloalkyl, and phenyl. 1 Examples of "alkyl (i.e., deuterated methyl)" may include -CD 3 、-CD 2 H, and -CDH 2 . "Deuterated C 3 -C 10 Examples of "cycloalkyl" may include Formula 10-501. "deuterated C 1 -C 60 Alkyl (or deuterated C 1 -C 20 Alkyl, etc.)", "deuterated C 3 -C 10 Cycloalkyl", "deuterated C 1 -C 10 "heterocycloalkyl" or "deuterated phenyl" may be: i) a fully deuterated C 1 -C 60 Alkyl (or fully deuterated C 1 -C 20 alkyl, etc.), fully deuterated C 3 -C 10 Cycloalkyl, fully deuterated C 1 -C 10 a fully deuterated phenyl group in which all hydrogen atoms are replaced by deuterium atoms, or ii) a partially deuterated C 1 -C 60 Alkyl (or partially deuterated C 1 -C 20 alkyl, etc.), partially deuterated C 3 -C 10 Cycloalkyl, partially deuterated C 1 -C 10 Heterocycloalkyl, or partially deuterated phenyl in which some of the hydrogen atoms are replaced by deuterium atoms.

[0551] “(C 1 -C 20 Alkyl)'X' group" refers to a 1 -C 20 Alkyl substituted 'X' group. For example, as used herein, "(C 1 -C 20 Alkyl)C 3 -C 10 "Cycloalkyl" refers to a cycloalkyl group consisting of at least one C 1 -C 20 Alkyl substituted C 3 -C10 Cycloalkyl, and as used herein, "(C 1 -C 20 "Alkyl)phenyl" refers to a 1 -C 20 Alkyl substituted phenyl. (C 1 -C 20 Examples of the alkyl)phenyl group may include tolyl.

[0552] In the present specification, “azaindole group, azabenzoborole group, azabenzophosphole group, azaindene group, azabenzosilole group, azabenzogermanol group, azabenzothiophene group, azabenzoselenophene group, azabenzofuran group, azacarbazole group, azadibenzoborole group, azadibenzophosphole group, azafluorene group, azadibenzosilole group, azadibenzogermanol group, azadibenzothiophene group, azadibenzoselenophene group, azadibenzofuran group, azadibenzothiophene 5-oxide group, aza-9H-fluoren-9-one group, and azadibenzothiophene 5,5-dione group” refers to an azadibenzothiophene 5,5-dione group. The “oxide group” each refers to a heterocycle in which at least one ring-forming carbon atom is replaced by a nitrogen atom and which has the same skeleton as the “indole group, benzoborole group, benzophosphole group, indene group, benzosilole group, benzogermanol group, benzothiophene group, benzoselenophene group, benzofuran group, carbazole group, dibenzoborole group, dibenzophosphole group, fluorene group, dibenzosilole group, dibenzogermanol group, dibenzothiophene group, dibenzoselenophene group, dibenzofuran group, dibenzothiophene 5-oxide group, 9H-fluoren-9-one group, and dibenzothiophene 5,5-dioxide group”, respectively.

[0553] Substituted C 5 -C 30 Carbocyclic groups, substituted C 1 -C 30 Heterocyclic groups, substituted C 1 -C 60 Alkyl, substituted C 2 -C 60 Alkenyl, substituted C 2 -C 60 Alkynyl, substituted C 1 -C 60 Alkoxy, substituted C 1 -C 60 Alkylthio, substituted C 3 -C 10 Cycloalkyl, substituted C 1 -C 10 Heterocycloalkyl, substituted C3 -C 10 Cycloalkenyl, substituted C 2 -C 10 Heterocycloalkenyl, substituted unsaturated C 1 -C 10 Heterocyclic groups, substituted C 6 -C 60 Aryl, substituted C 7 -C 60 Alkaryl, substituted C 6 -C 60 Aryloxy, substituted C 6 -C 60 Arylthio, substituted C 1 -C 60 Heteroaryl, substituted C 2 -C 60 The substituents of the alkylheteroaryl group, the substituted monovalent non-aromatic fused polycyclic group, and the substituted monovalent non-aromatic fused heteropolycyclic group may each independently be:

[0554] Deuterium, -F, -Cl, -Br, -I, -CD 3 、-CD 2 H.-CDH 2 , -CF 3 , -CF 2 H, -CFH 2 , hydroxyl, cyano, nitro, amidine, hydrazine, hydrazone, carboxylic acid or its salt, sulfonic acid or its salt, phosphoric acid or its salt, C 1 -C 60 Alkyl, C 2 -C 60 Alkenyl, C 2 -C 60 Alkynyl, or C 1 -C 60 Alkoxy;

[0555] Each of C is substituted by 1 -C 60 Alkyl, C 2 -C 60 Alkenyl, C 2 -C 60 Alkynyl, or C 1 -C 60 Alkoxy: deuterium, -F, -Cl, -Br, -I, -CD 3 、-CD 2 H.-CDH 2 , -CF 3 , -CF 2 H, -CFH 2, hydroxyl, cyano, nitro, amidine, hydrazine, hydrazone, carboxylic acid or its salt, sulfonic acid or its salt, phosphoric acid or its salt, C 3 -C 10 Cycloalkyl, C 1 -C 10 Heterocycloalkyl, C 3 -C 10 Cycloalkenyl, C 2 -C 10 Heterocycloalkenyl, unsaturated C 1 -C 10 Heterocyclic group, C 6 -C 60 Aryl, C 7 -C 60 Alkyl, C 6 -C 60 Aryloxy, C 6 -C 60 Arylthio, C 1 -C 60 Heteroaryl, C 2 -C 60 alkylheteroaryl, monovalent non-aromatic fused polycyclic group, monovalent non-aromatic fused heteropolycyclic group, -N(Q 11 )(Q 12 )、-Si(Q 13 )(Q 14 )(Q 15 )、-B(Q 16 )(Q 17 )、-P(=O)(Q 18 )(Q 19 )、-P(Q 18 )(Q 19 ), or any combination thereof;

[0556] C 3 -C 10 Cycloalkyl, C 1 -C 10 Heterocycloalkyl, C 3 -C 10 Cycloalkenyl, C 2 -C 10 Heterocycloalkenyl, unsaturated C 1 -C 10 Heterocyclic group, C 6 -C 60 Aryl, C 7 -C 60 Alkyl, C 6 -C 60 Aryloxy, C 6 -C 60 Arylthio, C 1 -C 60Heteroaryl, C 2 -C 60 an alkylheteroaryl group, a monovalent non-aromatic fused polycyclic group, or a monovalent non-aromatic fused heteropolycyclic group;

[0557] Each of C is substituted by 3 -C 10 Cycloalkyl, C 1 -C 10 Heterocycloalkyl, C 3 -C 10 Cycloalkenyl, C 2 -C 10 Heterocycloalkenyl, unsaturated C 1 -C 10 Heterocyclic group, C 6 -C 60 Aryl, C 7 -C 60 Alkyl, C 6 -C 60 Aryloxy, C 6 -C 60 Arylthio, C 1 -C 60 Heteroaryl, C 2 -C 60 Alkyl heteroaryl, monovalent non-aromatic fused polycyclic group, or monovalent non-aromatic fused heteropolycyclic group: deuterium, -F, -Cl, -Br, -I, -CD 3 、-CD 2 H.-CDH 2 , -CF 3 , -CF 2 H, -CFH 2 , hydroxyl, cyano, nitro, amidine, hydrazine, hydrazone, carboxylic acid or its salt, sulfonic acid or its salt, phosphoric acid or its salt, C 1 -C 60 Alkyl, C 2 -C 60 Alkenyl, C 2 -C 60 Alkynyl, C 1 -C 60 Alkoxy, C 3 -C 10 Cycloalkyl, C 1 -C 10 Heterocycloalkyl, C 3 -C 10 Cycloalkenyl, C 2 -C 10 Heterocycloalkenyl, unsaturated C 1 -C 10 Heterocyclic group, C 6 -C 60 Aryl, C7 -C 60 Alkyl, C 6 -C 60 Aryloxy, C 6 -C 60 Arylthio, C 1 -C 60 Heteroaryl, C 2 -C 60 alkylheteroaryl, monovalent non-aromatic fused polycyclic group, monovalent non-aromatic fused heteropolycyclic group, -N(Q 21 )(Q 22 )、-Si(Q 23 )(Q 24 )(Q 25 )、-B(Q 26 )(Q 27 )、-P(=O)(Q 28 )(Q 29 )、-P(Q 28 )(Q 29 ), or any combination thereof;

[0558] -N(Q 31 )(Q 32 )、-Si(Q 33 )(Q 34 )(Q 35 )、-B(Q 36 )(Q 37 )、-P(=O)(Q 38 )(Q 39 ), or -P(Q 38 )(Q 39 );or

[0559] Any combination thereof.

[0560] In this manual, Q 1 -Q 9 , Q 11 -Q 19 , Q 21 -Q 29 , and Q 31 -Q 39 can be independently: hydrogen; deuterium; -F; -Cl; -Br; -I; hydroxyl; cyano; nitro; amidino; hydrazine; hydrazone; carboxylic acid group or its salt; sulfonic acid group or its salt; phosphoric acid group or its salt; unsubstituted or substituted with deuterium, C 1 -C 60 Alkyl, C 6 -C 60 Aryl, or any combination thereof substituted C 1 -C 60 Alkyl; C 2 -C60 Alkenyl; C 2 -C 60 Alkynyl; C 1 -C 60 Alkoxy; C 3 -C 10 Cycloalkyl; C 1 -C 10 Heterocycloalkyl; C 3 -C 10 Cycloalkenyl; C 2 -C 10 Heterocycloalkenyl; unsaturated C 1 -C 10 Heterocyclic group; unsubstituted or substituted with deuterium, C 1 -C 60 Alkyl, C 6 -C 60 Aryl, or any combination thereof substituted C 6 -C 60 Aryl; C 6 -C 60 Aryloxy; C 6 -C 60 Arylthio; C 1 -C 60 heteroaryl; a monovalent non-aromatic fused polycyclic group; or a monovalent non-aromatic fused heteropolycyclic group.

[0561] Hereinafter, the compound and the organic light-emitting device according to the embodiment will be described in detail with reference to Synthesis Examples and Examples, however, the present disclosure is not limited thereto. The phrase "using B instead of A" used in describing Synthesis Examples means that the amount of B used is the same as the amount of A used based on molar equivalents.

[0562] Example

[0563] Synthesis Example 1 (Compound Pt-1)

[0564]

[0565] (1) Synthesis of intermediate Pt-1-IM2

[0566] 5.46 grams (g) (20 mmol) of 1-(3-bromophenyl)-1H-benzo[d]imidazole, 9.08 g (24 mmol) of 9-(4-(2-phenylpropane-2-yl)pyridin-2-yl)-9H-carbazole-2-ol, 0.76 g (4 mmol) of copper (I) iodide, 0.98 g (8 mmol) of picolinic acid, and 12.7 g (60 mmol) of tripotassium phosphate were mixed with 133 mL of dimethyl sulfoxide (DMSO) and then stirred at a temperature of 120° C. for 12 hours. Once the reaction was completed, the mixture was cooled to room temperature and then heated to room temperature using saturated ammonium chloride (NH 4 The organic layer extracted with aqueous solution of Cl and ethyl acetate (EA) was washed with anhydrous magnesium sulfate (MgSO 4 ) was dried and filtered, followed by concentration under reduced pressure. The resulting product was subjected to silica gel column chromatography to thereby obtain 7.42 g (13 mmol) of Intermediate Pt-1-IM2 (yield: 65%).

[0567] LC-MS (calculated value: 570.24 g / mol, measured value: M+1=571 g / mol)

[0568] (2) Synthesis of intermediate Pt-1-IM1

[0569] 7.42 g (13 mmol) of intermediate Pt-1-IM2, 11.40 g (19.5 mmol) of trifluoromethanesulfonic acid (3,5-di-tert-butylphenyl) ( Iodine 0.24 g (1.3 mmol) of copper (II) acetate was mixed with 130 mL of N,N-dimethylformamide (DMF) and then stirred at 100° C. for 4 hours. Once the reaction was complete, the mixture was cooled to room temperature and then heated with saturated NH 4 The organic layer extracted with aqueous Cl solution and EA was washed with anhydrous MgSO 4 Dried and filtered, followed by concentration under reduced pressure. The obtained product was subjected to silica gel column chromatography to thereby obtain 10.05 g (11.05 mmol) of Intermediate Pt-1-IM1 (yield: 85%).

[0570] LC-MS (calculated value: 759.41 g / mol, measured value: M+1=759 g / mol)

[0571] (3) Synthesis of compound Pt-1

[0572] 5.00 g (5.50 mmol) of intermediate Pt-1-IM1 and 2.26 g (6.05 mmol) of 1,5-cyclooctadiene platinum dichloride (Pt(COD)Cl 2), and 1.35 g (16.50 mmol) of sodium acetate were mixed with 275 mL of benzonitrile, followed by stirring at a temperature of 180° C. for 18 hours. Once the reaction was complete, the mixture was cooled to room temperature and concentrated under reduced pressure. The resulting product was subjected to silica gel column chromatography to thereby obtain 2.88 g (3.03 mmol) of compound Pt-1 (yield: 55%).

[0573] LC-MS (calculated value: 951.35 g / mol, measured value: M+1=952 g / mol)

[0574] Synthesis Example 2 (Compound Pt-2)

[0575]

[0576] (1) Synthesis of intermediate Pt-2-IM2

[0577] 5.46 g (20 mmol) of 1-(3-bromophenyl)-1H-benzo[d]imidazole, 7.59 g (24 mmol) of 9-(4-(tert-butyl)pyridin-2-yl)-9H-carbazole-2-ol, 0.76 g (4 mmol) of copper (I) iodide, 0.98 g (8 mmol) of picolinic acid, and 12.7 g (60 mmol) of tripotassium phosphate were mixed with 133 mL of DMSO and then stirred at 120° C. for 12 hours. Once the reaction was complete, the mixture was cooled to room temperature and then heated with saturated NH 4 The organic layer extracted with aqueous Cl solution and EA was washed with anhydrous MgSO 4 Dried and filtered, followed by concentration under reduced pressure. The resulting product was subjected to silica gel column chromatography to thereby obtain 6.92 g (13.60 mmol) of an intermediate Pt-2-IM2 (yield: 68%).

[0578] LC-MS (calculated value: 508.23 g / mol, measured value: M+1=509 g / mol)

[0579] (2) Synthesis of intermediate Pt-2-IM1

[0580] 6.92 g (13.60 mmol) of the intermediate Pt-2-IM2, 14.45 g (20.40 mmol) of trifluoromethanesulfonic acid (3,5-bis(2-phenylpropane-2-yl)phenyl) ( Iodine and 0.25 g (1.36 mmol) of copper (II) acetate were mixed with 136 mL of DMF and then stirred at 100° C. for 4 hours. Once the reaction was complete, the mixture was cooled to room temperature and then saturated with NH 4The organic layer extracted with aqueous Cl solution and EA was washed with anhydrous MgSO 4 Dried and filtered, followed by concentration under reduced pressure. The obtained product was subjected to silica gel column chromatography to thereby obtain 11.09 g (11.42 mmol) of Intermediate Pt-2-IM1 (yield: 84%).

[0581] LC-MS (calculated value: 821.42 g / mol, measured value: M+1=821 g / mol)

[0582] (3) Synthesis of compound Pt-2

[0583] 5.34 g (5.50 mmol) of intermediate Pt-2-IM1, 2.26 g (6.05 mmol) of Pt(COD)Cl 2 , and 1.35g (16.50mmol) of sodium acetate were mixed with 275mL of benzonitrile, and then stirred at a temperature of 180°C for 18 hours. Once the reaction was completed, the mixture was cooled to room temperature and concentrated under reduced pressure. The resulting product was subjected to silica gel column chromatography to thereby obtain 2.96g (2.92mmol) of compound Pt-2 (yield: 53%).

[0584] LC-MS (calculated value: 1013.36 g / mol, measured value: M+1=1014 g / mol)

[0585] Synthesis Example 3 (Compound Pt-3)

[0586]

[0587] (1) Synthesis of intermediate Pt-3-IM2

[0588] 7.83 g (20 mmol) of 1-(3-bromo-5-(2-phenylpropane-2-yl)phenyl)-1H-benzo[d]imidazole, 7.59 g (24 mmol) of 9-(4-(tert-butyl)pyridin-2-yl)-9H-carbazole-2-ol, 0.76 g (4 mmol) of copper (I) iodide, 0.98 g (8 mmol) of picolinic acid, and 12.7 g (60 mmol) of tripotassium phosphate were mixed with 133 mL of DMSO and then stirred at 120° C. for 12 hours. Once the reaction was complete, the mixture was cooled to room temperature and then heated with saturated NH 4 The organic layer extracted with aqueous Cl solution and EA was washed with anhydrous MgSO 4 Dried and filtered, followed by concentration under reduced pressure. The resulting product was subjected to silica gel column chromatography to thereby obtain 7.77 g (12.40 mmol) of an intermediate Pt-3-IM2 (yield: 62%).

[0589] LC-MS (calculated value: 626.31 g / mol, measured value: M+1=627 g / mol)

[0590] (2) Synthesis of intermediate Pt-3-IM1

[0591] 7.77 g (12.40 mmol) of the intermediate Pt-3-IM2, 10.87 g (18.60 mmol) of trifluoromethanesulfonic acid (3,5-di-tert-butylphenyl) ( Iodine and 0.23 g (1.24 mmol) of copper (II) acetate were mixed with 124 mL of DMF and then stirred at 100° C. for 4 hours. Once the reaction was complete, the mixture was cooled to room temperature and then saturated with NH 4 The organic layer extracted with aqueous Cl solution and EA was washed with anhydrous MgSO 4 Dried and filtered, followed by concentration under reduced pressure. The obtained product was subjected to silica gel column chromatography to thereby obtain 11.09 g (11.42 mmol) of Intermediate Pt-3-IM1 (yield: 84%).

[0592] LC-MS (calculated value: 815.47 g / mol, measured value: M+1=816 g / mol)

[0593] (3) Synthesis of compound Pt-3

[0594] 5.31 g (5.50 mmol) of intermediate Pt-3-IM1, 2.26 g (6.05 mmol) of Pt(COD)Cl 2 , and 1.35g (16.50mmol) of sodium acetate were mixed with 275mL of benzonitrile, and then stirred at a temperature of 180°C for 18 hours. Once the reaction was completed, the mixture was cooled to room temperature and concentrated under reduced pressure. The resulting product was subjected to silica gel column chromatography to thereby obtain 2.94g (2.92mmol) of compound Pt-3 (yield: 53%).

[0595] LC-MS (calculated value: 1007.41 g / mol, measured value: M+1=1008 g / mol)

[0596] Synthesis Example 4 (Compound Pt-4)

[0597]

[0598] (1) Synthesis of intermediate Pt-4-IM2

[0599] 5.46 g (20 mmol) of 1-(3-bromophenyl)-1H-benzo[d]imidazole, 10.43 g (24 mmol) of 6-(tert-butyl)-9-(4-(2-phenylpropane-2-yl)pyridin-2-yl)-9H-carbazole-2-ol, 0.76 g (4 mmol) of copper (I) iodide, 0.98 g (8 mmol) of picolinic acid, and 12.7 g (60 mmol) of tripotassium phosphate were mixed with 133 mL of DMSO and then stirred at 120° C. for 12 hours. Once the reaction was complete, the mixture was cooled to room temperature and then heated with saturated NH 4 The organic layer extracted with aqueous Cl solution and EA was washed with anhydrous MgSO 4 Dried and filtered, followed by concentration under reduced pressure. The resulting product was subjected to silica gel column chromatography to thereby obtain 8.40 g (13.40 mmol) of an intermediate Pt-4-IM2 (yield: 67%).

[0600] LC-MS (calculated value: 626.31 g / mol, measured value: M+1=627 g / mol)

[0601] (2) Synthesis of intermediate Pt-4-IM1

[0602] 8.40 g (13.40 mmol) of the intermediate Pt-4-IM2, 11.75 g (20.10 mmol) of trifluoromethanesulfonic acid (3,5-di-tert-butylphenyl) ( Iodine and 0.24 g (1.34 mmol) of copper (II) acetate were mixed with 124 mL of DMF and then stirred at 100° C. for 4 hours. Once the reaction was complete, the mixture was cooled to room temperature and then saturated with NH 4 The organic layer extracted with aqueous Cl solution and EA was washed with anhydrous MgSO 4 Dried and filtered, followed by concentration under reduced pressure. The obtained product was subjected to silica gel column chromatography to thereby obtain 11.09 g (11.42 mmol) of Intermediate Pt-4-IM1 (yield: 84%).

[0603] LC-MS (calculated value: 815.47 g / mol, measured value: M+1=816 g / mol)

[0604] (3) Synthesis of compound Pt-4

[0605] 5.31 g (5.50 mmol) of intermediate Pt-4-IM1, 2.26 g (6.05 mmol) of Pt(COD)Cl 2, and 1.35g (16.50mmol) of sodium acetate were mixed with 275mL of benzonitrile, and then stirred at a temperature of 180°C for 18 hours. Once the reaction was completed, the mixture was cooled to room temperature and concentrated under reduced pressure. The resulting product was subjected to silica gel column chromatography to thereby obtain 2.94g (2.92mmol) of compound Pt-4 (yield: 53%).

[0606] LC-MS (calculated value: 1007.41 g / mol, measured value: M+1=1008 g / mol)

[0607] Synthesis Example 5 (Compound Pt-5)

[0608]

[0609] (1) Synthesis of intermediate Pt-5-IM2

[0610] 5.46 g (20 mmol) of 1-(3-bromophenyl)-1H-benzo[d]imidazole, 10.91 g (24 mmol) of 6-phenyl-9-(4-(2-phenylpropane-2-yl)pyridin-2-yl)-9H-carbazole-2-ol, 0.76 g (4 mmol) of copper (I) iodide, 0.98 g (8 mmol) of picolinic acid, and 12.7 g (60 mmol) of tripotassium phosphate were mixed with 133 mL of DMSO and then stirred at 120° C. for 12 hours. Once the reaction was complete, the mixture was cooled to room temperature and then heated with saturated NH 4 The organic layer extracted with aqueous Cl solution and EA was washed with anhydrous MgSO 4 Dried and filtered, followed by concentration under reduced pressure. The resulting product was subjected to silica gel column chromatography to thereby obtain 6.86 g (10.60 mmol) of an intermediate Pt-5-IM2 (yield: 53%).

[0611] LC-MS (calculated value: 646.27 g / mol, measured value: M+1=647 g / mol)

[0612] (2) Synthesis of intermediate Pt-5-IM1

[0613] 6.86 g (10.60 mmol) of intermediate Pt-5-IM2, 9.29 g (15.90 mmol) of trifluoromethanesulfonic acid (3,5-di-tert-butylphenyl) ( Iodine and 0.19 g (1.06 mmol) of copper (II) acetate were mixed with 106 mL of DMF and then stirred at 100° C. for 4 hours. Once the reaction was complete, the mixture was cooled to room temperature and then saturated with NH 4The organic layer extracted with aqueous Cl solution and EA was washed with anhydrous MgSO 4 Dried and filtered, followed by concentration under reduced pressure. The obtained product was subjected to silica gel column chromatography to thereby obtain 8.56 g (8.69 mmol) of Intermediate Pt-5-IM1 (yield: 82%).

[0614] LC-MS (calculated value: 835.44 g / mol, measured value: M+1=836 g / mol)

[0615] (3) Synthesis of compound Pt-5

[0616] 5.42 g (5.50 mmol) of intermediate Pt-5-IM1, 2.26 g (6.05 mmol) of Pt(COD)Cl 2 , and 1.35g (16.50mmol) of sodium acetate were mixed with 275mL of benzonitrile, followed by stirring at a temperature of 180°C for 18 hours. Once the reaction was complete, the mixture was cooled to room temperature and concentrated under reduced pressure. The resulting product was subjected to silica gel column chromatography to thereby obtain 3.11g (3.03mmol) of compound Pt-5 (yield: 55%).

[0617] LC-MS (calculated value: 1027.38 g / mol, measured value: M+1=1028 g / mol)

[0618] Synthesis Example 6 (Compound Pt-6)

[0619]

[0620] (1) Synthesis of intermediate Pt-6-IM2

[0621] 6.58 g (20 mmol) of 1-(3-bromo-5-(tert-butyl)phenyl)-1H-benzo[d]imidazole, 9.08 g (24 mmol) of 9-(4-(2-phenylpropane-2-yl)pyridin-2-yl)-9H-carbazole-2-ol, 0.76 g (4 mmol) of copper (I) iodide, 0.98 g (8 mmol) of picolinic acid, and 12.7 g (60 mmol) of tripotassium phosphate were mixed with 133 mL of DMSO and then stirred at 120° C. for 12 hours. Once the reaction was complete, the mixture was cooled to room temperature and then heated with saturated NH 4 The organic layer extracted with aqueous Cl solution and EA was washed with anhydrous MgSO 4 Dried and filtered, followed by concentration under reduced pressure. The resulting product was subjected to silica gel column chromatography to thereby obtain 6.64 g (10.60 mmol) of an intermediate Pt-6-IM2 (yield: 53%).

[0622] LC-MS (calculated value: 626.31 g / mol, measured value: M+1=627 g / mol)

[0623] (2) Synthesis of intermediate Pt-6-IM1

[0624] 6.64 g (10.60 mmol) of intermediate Pt-6-IM2, 9.29 g (15.90 mmol) of trifluoromethanesulfonic acid (3,5-di-tert-butylphenyl) ( Iodine and 0.19 g (1.06 mmol) of copper (II) acetate were mixed with 106 mL of DMF and then stirred at 100° C. for 4 hours. Once the reaction was complete, the mixture was cooled to room temperature and then saturated with NH 4 The organic layer extracted with aqueous Cl solution and EA was washed with anhydrous MgSO 4 Dried and filtered, followed by concentration under reduced pressure. The obtained product was subjected to silica gel column chromatography to thereby obtain 8.29 g (8.59 mmol) of an intermediate Pt-6-IM1 (yield: 81%).

[0625] LC-MS (calculated value: 815.47 g / mol, measured value: M+1=816 g / mol)

[0626] (3) Synthesis of compound Pt-6

[0627] 5.31 g (5.50 mmol) of intermediate Pt-6-IM1, 2.26 g (6.05 mmol) of Pt(COD)Cl 2 , and 1.35g (16.50mmol) of sodium acetate were mixed with 275mL of benzonitrile, and then stirred at a temperature of 180°C for 18 hours. Once the reaction was completed, the mixture was cooled to room temperature and concentrated under reduced pressure. The resulting product was subjected to silica gel column chromatography to thereby obtain 3.33g (3.30mmol) of compound Pt-6 (yield: 60%).

[0628] LC-MS (calculated value: 1007.41 g / mol, measured value: M+1=1008 g / mol)

[0629] Synthesis Example 7 (Compound Pt-7)

[0630]

[0631] (1) Synthesis of intermediate Pt-7-IM1

[0632] 5.02 g (20 mmol) of 1-(3-bromophenyl)-3,5-dimethyl-1H-pyrazole, 9.08 g (24 mmol) of 9-(4-(2-phenylpropane-2-yl)pyridin-2-yl)-9H-carbazole-2-ol, 0.76 g (4 mmol) of copper (I) iodide, 0.98 g (8 mmol) of picolinic acid, and 12.7 g (60 mmol) of tripotassium phosphate were mixed with 133 mL of DMSO and then stirred at 120° C. for 12 hours. Once the reaction was completed, the mixture was cooled to room temperature and then heated with saturated NH 4 The organic layer extracted with aqueous Cl solution and EA was washed with anhydrous MgSO 4 Dried and filtered, followed by concentration under reduced pressure. The obtained product was subjected to silica gel column chromatography to thereby obtain 6.04 g (11.00 mmol) of Intermediate Pt-7-IM1 (yield: 55%).

[0633] LC-MS (calculated value: 548.26 g / mol, measured value: M+1=549 g / mol)

[0634] (2) Synthesis of compound Pt-7

[0635] 3.02 g (5.50 mmol) of intermediate Pt-7-IM1 and 2.11 g (6.05 mmol) of PtCl 2 (PhCN) 2 It was mixed with 275 mL of benzonitrile, followed by stirring at a temperature of 180° C. for 18 hours. Once the reaction was completed, the mixture was cooled to room temperature and concentrated under reduced pressure. The resulting product was subjected to silica gel column chromatography to thereby obtain 2.24 g (3.03 mmol) of compound Pt-7 (yield: 55%).

[0636] LC-MS (calculated value: 741.21 g / mol, measured value: M+1=742 g / mol)

[0637] Synthesis Example 8 (Compound Pt-8)

[0638]

[0639] (1) Synthesis of intermediate Pt-8-IM1

[0640] 5.98 g (20 mmol) of 2-(3-bromophenyl)-1-phenyl-1H-imidazole, 9.08 g (24 mmol) of 9-(4-(2-phenylpropane-2-yl)pyridin-2-yl)-9H-carbazole-2-ol, 0.76 g (4 mmol) of copper (I) iodide, 0.98 g (8 mmol) of picolinic acid, and 12.7 g (60 mmol) of tripotassium phosphate were mixed with 133 mL of DMSO, followed by stirring at 120° C. for 12 hours. Once the reaction was complete, the mixture was cooled to room temperature, and then saturated NH 4 The organic layer extracted with aqueous Cl solution and EA was washed with anhydrous MgSO 4 Dried and filtered, followed by concentration under reduced pressure. The obtained product was subjected to silica gel column chromatography to thereby obtain 5.85 g (9.80 mmol) of Intermediate Pt-8-IM1 (yield: 49%).

[0641] LC-MS (calculated value: 596.26 g / mol, measured value: M+1=597 g / mol)

[0642] (2) Synthesis of compound Pt-8

[0643] 3.28 g (5.50 mmol) of intermediate Pt-8-IM1 and 2.11 g (6.05 mmol) of PtCl 2 (PhCN) 2 It was mixed with 275 mL of benzonitrile, followed by stirring at a temperature of 180° C. for 18 hours. Once the reaction was completed, the mixture was cooled to room temperature and concentrated under reduced pressure. The resulting product was subjected to silica gel column chromatography to thereby obtain 2.43 g (3.08 mmol) of compound Pt-8 (yield: 56%).

[0644] LC-MS (calculated value: 789.21 g / mol, measured value: M+1=790 g / mol)

[0645] Synthesis Example 9 (Compound Pt-9)

[0646]

[0647] (1) Synthesis of intermediate Pt-9-IM2

[0648] 5.46 g (20 mmol) of 1-(3-bromophenyl)-1H-benzo[d]imidazole, 10.56 g (24 mmol) of 9-(4-(1,1-diphenylethyl)pyridin-2-yl)-9H-carbazole-2-ol, 0.76 g (4 mmol) of copper (I) iodide, 0.98 g (8 mmol) of picolinic acid, and 12.7 g (60 mmol) of tripotassium phosphate were mixed with 133 mL of DMSO and then stirred at 120° C. for 12 hours. Once the reaction was complete, the mixture was cooled to room temperature and then heated with saturated NH 4 The organic layer extracted with aqueous Cl solution and EA was washed with anhydrous MgSO 4 Dried and filtered, followed by concentration under reduced pressure. The resulting product was subjected to silica gel column chromatography to thereby obtain 6.70 g (10.60 mmol) of an intermediate Pt-9-IM2 (yield: 53%).

[0649] LC-MS (calculated value: 632.26 g / mol, measured value: M+1=633 g / mol)

[0650] (2) Synthesis of intermediate Pt-9-IM1

[0651] 6.86 g (10.60 mmol) of intermediate Pt-9-IM2, 9.29 g (15.90 mmol) of trifluoromethanesulfonic acid (3,5-di-tert-butylphenyl) ( Iodine and 0.19 g (1.06 mmol) of copper (II) acetate were mixed with 106 mL of DMF and then stirred at 100° C. for 4 hours. Once the reaction was complete, the mixture was cooled to room temperature and then saturated with NH 4 The organic layer extracted with aqueous Cl solution and EA was washed with anhydrous MgSO 4 Dried and filtered, followed by concentration under reduced pressure. The obtained product was subjected to silica gel column chromatography to thereby obtain 8.43 g (8.69 mmol) of an intermediate Pt-9-IM1 (yield: 82%).

[0652] LC-MS (calculated value: 821.44 g / mol, measured value: M+1=821 g / mol)

[0653] (3) Synthesis of compound Pt-9

[0654] 5.34 g (5.50 mmol) of intermediate Pt-9-IM1, 2.26 g (6.05 mmol) of Pt(COD)Cl 2, and 1.35g (16.50mmol) of sodium acetate were mixed with 275mL of benzonitrile, and then stirred at a temperature of 180°C for 18 hours. Once the reaction was completed, the mixture was cooled to room temperature and concentrated under reduced pressure. The resulting product was subjected to silica gel column chromatography to thereby obtain 3.07g (3.03mmol) of compound Pt-9 (yield: 55%).

[0655] LC-MS (calculated value: 1013.36 g / mol, measured value: M+1=1014 g / mol)

[0656] Synthesis Example 10 (Compound Pt-10)

[0657]

[0658] (1) Synthesis of intermediate Pt-10-IM2

[0659] 5.46 g (20 mmol) of 1-(3-bromophenyl)-1H-benzo[d]imidazole, 12.39 g (24 mmol) of 9-(4-(1,1-diphenylethyl)pyridin-2-yl)-6-phenyl-9H-carbazole-2-ol, 0.76 g (4 mmol) of copper (I) iodide, 0.98 g (8 mmol) of picolinic acid, and 12.7 g (60 mmol) of tripotassium phosphate were mixed with 133 mL of DMSO and then stirred at 120° C. for 12 hours. Once the reaction was complete, the mixture was cooled to room temperature and then heated with saturated NH 4 The organic layer extracted with aqueous Cl solution and EA was washed with anhydrous MgSO 4 Dried and filtered, followed by concentration under reduced pressure. The obtained product was subjected to silica gel column chromatography to thereby obtain 7.08 g (10.00 mmol) of an intermediate Pt-10-IM2 (yield: 50%).

[0660] LC-MS (calculated value: 708.29 g / mol, measured value: M+1=709 g / mol)

[0661] (2) Synthesis of intermediate Pt-10-IM1

[0662] 7.08 g (10.00 mmol) of the intermediate Pt-10-IM2, 8.76 g (15.00 mmol) of trifluoromethanesulfonic acid (3,5-di-tert-butylphenyl) ( Iodine and 0.19 g (1.00 mmol) of copper (II) acetate were mixed with 100 mL of DMF and then stirred at 100° C. for 4 hours. Once the reaction was complete, the mixture was cooled to room temperature and then saturated with NH 4The organic layer extracted with aqueous Cl solution and EA was washed with anhydrous MgSO 4 Dried and filtered, followed by concentration under reduced pressure. The obtained product was subjected to silica gel column chromatography to thereby obtain 8.37 g (8.00 mmol) of Intermediate Pt-10-IM1 (yield: 80%).

[0663] LC-MS (calculated value: 897.45 g / mol, measured value: M+1=898 g / mol)

[0664] (3) Synthesis of compound Pt-10

[0665] 5.76 g (5.50 mmol) of intermediate Pt-10-IM1, 2.26 g (6.05 mmol) of Pt(COD)Cl 2 , and 1.35g (16.50mmol) of sodium acetate were mixed with 275mL of benzonitrile, and then stirred at a temperature of 180°C for 18 hours. Once the reaction was completed, the mixture was cooled to room temperature and concentrated under reduced pressure. The resulting product was subjected to silica gel column chromatography to thereby obtain 3.06g (2.81mmol) of compound Pt-10 (yield: 51%).

[0666] LC-MS (calculated value: 1089.40 g / mol, measured value: M+1=1090 g / mol)

[0667] Synthesis Example 11 (Compound Pt-13)

[0668]

[0669] (1) Synthesis of intermediate Pt-13-IM2

[0670] 5.46 g (20 mmol) of 1-(3-bromophenyl)-1H-benzo[d]imidazole, 10.42 g (24 mmol) of 9-(4-(tert-butyl)pyridin-2-yl)-6-(2-phenylpropane-2-yl)-9H-carbazole-2-ol, 0.76 g (4 mmol) of copper (I) iodide, 0.98 g (8 mmol) of picolinic acid, and 12.7 g (60 mmol) of tripotassium phosphate were mixed with 133 mL of DMSO and then stirred at 120° C. for 12 hours. Once the reaction was complete, the mixture was cooled to room temperature and then heated with saturated NH 4 The organic layer extracted with aqueous Cl solution and EA was washed with anhydrous MgSO 4 Dried and filtered, followed by concentration under reduced pressure. The obtained product was subjected to silica gel column chromatography to thereby obtain 6.89 g (11.00 mmol) of Intermediate Pt-13-IM2 (yield: 55%).

[0671] LC-MS (calculated value: 626.31 g / mol, measured value: M+1=627 g / mol)

[0672] (2) Synthesis of intermediate Pt-13-IM1

[0673] 6.89 g (11.00 mmol) of intermediate Pt-13-IM2, 9.64 g (16.50 mmol) of trifluoromethanesulfonic acid (3,5-di-tert-butylphenyl) ( Iodine and 0.20 g (1.10 mmol) of copper (II) acetate were mixed with 110 mL of DMF and then stirred at 100° C. for 4 hours. Once the reaction was complete, the mixture was cooled to room temperature and then saturated with NH 4 The organic layer extracted with aqueous Cl solution and EA was washed with anhydrous MgSO 4 Dried and filtered, followed by concentration under reduced pressure. The obtained product was subjected to silica gel column chromatography to thereby obtain 8.49 g (8.80 mmol) of Intermediate Pt-13-IM1 (yield: 80%).

[0674] LC-MS (calculated value: 815.47 g / mol, measured value: M+1=816 g / mol)

[0675] (3) Synthesis of compound Pt-13

[0676] 5.30 g (5.50 mmol) of intermediate Pt-13-IM1, 2.26 g (6.05 mmol) of Pt(COD)Cl 2 , and 1.35g (16.50mmol) of sodium acetate were mixed with 275mL of benzonitrile, and then stirred at a temperature of 180°C for 18 hours. Once the reaction was completed, the mixture was cooled to room temperature and concentrated under reduced pressure. The resulting product was subjected to silica gel column chromatography to thereby obtain 2.83g (2.81mmol) of compound Pt-13 (yield: 51%).

[0677] LC-MS (calculated value: 1007.41 g / mol, measured value: M+1=1008 g / mol)

[0678] Synthesis Example 12 (Compound Pt-17)

[0679]

[0680] (1) Synthesis of intermediate Pt-17-IM2

[0681] 5.46 g (20 mmol) of 1-(3-bromophenyl)-1H-benzo[d]imidazole, 10.42 g (24 mmol) of 9-(4-(2-(4-(tert-butyl)phenyl)propane-2-yl)pyridin-2-yl)-9H-carbazole-2-ol, 0.76 g (4 mmol) of copper (I) iodide, 0.98 g (8 mmol) of picolinic acid, and 12.7 g (60 mmol) of tripotassium phosphate were mixed with 133 mL of DMSO and then stirred at 120° C. for 12 hours. Once the reaction was complete, the mixture was cooled to room temperature and then heated with saturated NH 4 The organic layer extracted with aqueous Cl solution and EA was washed with anhydrous MgSO 4 Dried and filtered, followed by concentration under reduced pressure. The obtained product was subjected to silica gel column chromatography to thereby obtain 6.89 g (11.00 mmol) of Intermediate Pt-17-IM2 (yield: 55%).

[0682] LC-MS (calculated value: 626.31 g / mol, measured value: M+1=627 g / mol)

[0683] (2) Synthesis of intermediate Pt-17-IM1

[0684] 6.89 g (11.00 mmol) of intermediate Pt-17-IM2, 9.64 g (16.50 mmol) of trifluoromethanesulfonic acid (3,5-di-tert-butylphenyl) ( Iodine and 0.20 g (1.10 mmol) of copper (II) acetate were mixed with 110 mL of DMF and then stirred at 100° C. for 4 hours. Once the reaction was complete, the mixture was cooled to room temperature and then saturated with NH 4 The organic layer extracted with aqueous Cl solution and EA was washed with anhydrous MgSO 4 Dried and filtered, followed by concentration under reduced pressure. The obtained product was subjected to silica gel column chromatography to thereby obtain 8.49 g (8.80 mmol) of Intermediate Pt-17-IM1 (yield: 80%).

[0685] LC-MS (calculated value: 815.47 g / mol, measured value: M+1=816 g / mol)

[0686] (3) Synthesis of compound Pt-17

[0687] 5.30 g (5.50 mmol) of intermediate Pt-17-IM1, 2.26 g (6.05 mmol) of Pt(COD)Cl 2, and 1.35g (16.50mmol) of sodium acetate were mixed with 275mL of benzonitrile, and then stirred at a temperature of 180°C for 18 hours. Once the reaction was complete, the mixture was cooled to room temperature and concentrated under reduced pressure. The resulting product was subjected to silica gel column chromatography to thereby obtain 2.94g (2.92mmol) of compound Pt-17 (yield: 53%).

[0688] LC-MS (calculated value: 1007.41 g / mol, measured value: M+1=1008 g / mol)

[0689] Synthesis Example 13 (Compound Pt-18)

[0690]

[0691] (1) Intermediate Pt-18-IM2

[0692] 5.46 g (20 mmol) of 1-(3-bromophenyl)-1H-benzo[d]imidazole, 11.78 g (24 mmol) of 9-(4-(2-(3,5-di-tert-butylphenyl)propane-2-yl)pyridin-2-yl)-9H-carbazole-2-ol, 0.76 g (4 mmol) of copper (I) iodide, 0.98 g (8 mmol) of picolinic acid, and 12.7 g (60 mmol) of tripotassium phosphate were mixed with 133 mL of DMSO and then stirred at 120° C. for 12 hours. Once the reaction was complete, the mixture was cooled to room temperature and then heated with saturated NH 4 The organic layer extracted with aqueous Cl solution and EA was washed with anhydrous MgSO 4 Dried and filtered, followed by concentration under reduced pressure. The obtained product was subjected to silica gel column chromatography to thereby obtain 7.78 g (11.40 mmol) of an intermediate Pt-18-IM2 (yield: 57%).

[0693] LC-MS (calculated value: 682.37 g / mol, measured value: M+1=683 g / mol)

[0694] (2) Synthesis of intermediate Pt-18-IM1

[0695] 7.78 g (11.40 mmol) of intermediate Pt-18-IM2, 9.99 g (17.10 mmol) of trifluoromethanesulfonic acid (3,5-di-tert-butylphenyl) ( Iodine and 0.21 g (1.14 mmol) of copper (II) acetate were mixed with 114 mL of DMF and then stirred at 100° C. for 4 hours. Once the reaction was complete, the mixture was cooled to room temperature and then saturated with NH 4The organic layer extracted with aqueous Cl solution and EA was washed with anhydrous MgSO 4 Dried and filtered, followed by concentration under reduced pressure. The obtained product was subjected to silica gel column chromatography to thereby obtain 9.66 g (9.46 mmol) of Intermediate Pt-18-IM1 (yield: 83%).

[0696] LC-MS (calculated value: 871.53 g / mol, measured value: M+1=872 g / mol)

[0697] (3) Synthesis of compound Pt-18

[0698] 5.62 g (5.50 mmol) of intermediate Pt-18-IM1, 2.26 g (6.05 mmol) of Pt(COD)Cl 2 , and 1.35g (16.50mmol) of sodium acetate were mixed with 275mL of benzonitrile, followed by stirring at a temperature of 180°C for 18 hours. Once the reaction was complete, the mixture was cooled to room temperature and concentrated under reduced pressure. The resulting product was subjected to silica gel column chromatography to thereby obtain 3.22g (3.03mmol) of compound Pt-18 (yield: 55%).

[0699] LC-MS (calculated value: 1063.47 g / mol, measured value: M+1=1064 g / mol)

[0700] Among the compounds synthesized in the above synthesis examples, in compound Pt-7 and compound Pt-8, the two bonds between N and Pt are coordination bonds, and the two bonds between C and Pt are covalent bonds; and in the remaining compounds, the bond between N and Pt and the bond between C and Pt of the benzimidazole ring are coordination bonds, and the two bonds between C and Pt of the benzene ring are covalent bonds.

[0701] Evaluation Example 1: Evaluation of Photoluminescence (PL) Spectra

[0702] Compound Pt-1 was diluted in toluene at a concentration of 10 millimoles / liter (mM), and the PL spectrum of compound Pt-1 was measured by using an ISC PC1 fluorescence spectrophotometer equipped with a xenon lamp. The same process was performed for compounds Pt-2 to Pt-6, Pt-9, Pt-10, Pt-13, Pt-17, and Pt-18. The maximum emission wavelength and FWHM of the compounds are shown in Table 2.

[0703] Table 2

[0704]

[0705]

[0706] Referring to the results of Table 2, it was found that compounds Pt-1 to Pt-6, Pt-9, Pt-10, Pt-13, Pt-17, and Pt-18 emitted blue light having a narrow FWHM.

[0707] Example 1

[0708] Will have A glass substrate having an indium tin oxide (ITO) electrode (as a first electrode (anode)) deposited thereon with a thickness of 1000 Å was washed with distilled water in the presence of ultrasonic waves. Once the washing with distilled water was completed, the substrate was ultrasonically washed by using isopropyl alcohol, acetone, and methanol in the order stated. Subsequently, the substrate was dried, transferred to a plasma cleaner, washed with oxygen plasma for 5 minutes, and mounted in a vacuum deposition apparatus.

[0709] Compound HT3 was vacuum deposited on the ITO electrode of the glass substrate to form a A first hole injection layer having a thickness of about 1000 mm was prepared by vacuum depositing compound HT-D1 on the first hole injection layer to form a first hole injection layer having a thickness of about 1000 mm. A second hole injection layer having a thickness of about 1000 mm was formed by vacuum depositing TAPC on the second hole injection layer. An electron blocking layer with a thickness of , thereby forming a hole transport region.

[0710] Compound H52 and compound Pt-1 (10 wt%) were co-deposited on the hole transport region to form a The thickness of the emission layer.

[0711] Compound ET3 was vacuum deposited on the emission layer to form a The electron transport layer is formed by depositing ET-D1(Liq) on the electron transport layer to form a layer having a thickness of about An electron injection layer having a thickness of about 1000 nm is formed, and an Al second electrode (cathode) is formed on the electron injection layer to have a thickness of about 1000 nm. The thickness of the organic light-emitting device is thus completed.

[0712]

[0713] Examples 1-6 and Comparative Examples A and B

[0714] An organic light emitting device was manufactured in substantially the same manner as in Example 1, except that in the formation of the emission layer, the compound shown in Table 3 was used as a dopant instead of the compound Pt-1.

[0715] Evaluation Example 2: Evaluation of Characteristics of Organic Light-Emitting Device

[0716] The maximum emission wavelength of the EL spectrum, the driving voltage, the external quantum efficiency (EQE), and the lifetime (LT) of the organic light-emitting devices manufactured in Examples 1 to 6 and Comparative Examples A and B were evaluated. 95 The results are shown in Table 3. Lifespan (LT 95 ) represents the time (hours) taken for the brightness of each light-emitting device to drop to 95% of its initial brightness of 100%. The brightness of the manufactured organic light-emitting devices was measured by using a brightness meter (Minolta Cs-1000A) at 1,000 candela / m2 (cd / m 2 ) at a brightness of . Then, the maximum emission wavelength was evaluated. A Keithley 2400 current-voltage meter and a brightness meter (Minolta Cs-1000A) were used in the evaluation of the driving voltage and the external quantum luminescence efficiency. In Table 3, the driving voltage, external quantum luminescence efficiency and life of the organic light-emitting devices manufactured in Examples 1-6 and Comparative Example B are shown as relative values ​​(%).

[0717] Table 3

[0718]

[0719]

[0720] Referring to Table 3, it was found that the organic light-emitting devices of Examples 1 to 6 had improved driving voltage, improved external quantum luminescence efficiency, and improved lifespan compared to the organic light-emitting devices of Comparative Examples A and B.

[0721] Example 7

[0722] An organic light-emitting device was manufactured in substantially the same manner as in Example 1, except that instead of Compound H52 and Compound Pt-1, CBP, Compound Pt-1, and Compound FD16 were co-deposited in a weight ratio of 88.5:10:1.5 to form an emission layer.

[0723] Comparative Example C

[0724] An organic light emitting device was manufactured in substantially the same manner as in Example 1, except that CBP and Compound FD16 were co-deposited at a weight ratio of 90:10 to form an emission layer instead of Compound H52 and Compound Pt-1.

[0725] Evaluation Example 3: Evaluation of Characteristics of Organic Light-Emitting Device

[0726] The maximum emission wavelength of the EL spectrum, the driving voltage, the external quantum efficiency, and the lifetime (LT) of the organic light-emitting devices manufactured in Example 7 and Comparative Example C were evaluated in substantially the same manner as in Evaluation Example 2. 95). The results are shown in Table 4. In Table 4, the driving voltage, external quantum luminescence efficiency and lifetime of the organic light emitting devices manufactured in Example 7 and Comparative Example C are shown as relative values ​​(%).

[0727] Table 4

[0728]

[0729]

[0730] Referring to Table 4, it was found that the organic light-emitting device of Example 7 had improved driving voltage, improved external quantum luminescence efficiency, and improved lifespan compared to the organic light-emitting device of Comparative Example C.

[0731] Since the organometallic compound has excellent thermal stability and electrical characteristics, an electronic device including the organometallic compound, such as an organic light emitting device, may have improved driving voltage, improved external quantum efficiency, and improved lifespan characteristics and emit light having a relatively narrow FWHM.

[0732] It should be understood that the embodiments described herein should be considered in a descriptive sense only and not for limiting purposes. The description of features or aspects in each embodiment should typically be considered to be applicable to other similar features or aspects in other embodiments. Although one or more embodiments have been described with reference to the accompanying drawings, it will be understood by those of ordinary skill in the art that various changes in form and detail may be made therein without departing from the spirit and scope as defined by the appended claims.

Claims

1. An organometallic compound represented by formula 1: Formula 1 in, In formula 1, M is Pt. X in Formula 1 1 -X 4 are each independently C or N, In formula 1, at X 1 The key between X 2 The key between X 3 and M, and the key between X 4 Two of the bonds between and M are each coordinate bonds, and the remaining are each covalent bonds, Z in Formula 1 1 -Z 4 Each is independently a group represented by Formula 2: Formula 2 In Formula 1, b1 and b2 are 0, b3 and b4 are each independently an integer of 0 to 20, and the sum of b1 to b4 is 1 or greater, Ring CY in Formula 1 1 To Ring CY 4 Each independently is C 5 -C 30 Carbocyclic group or C 1 -C 30 Heterocyclic groups, T in Formula 1 1 is *-S-*', *-Se-*', or *-O-*', T in Formula 1 2 is a single bond, T in Formula 1 3 is a single bond, T in Formula 1 4 is a single bond, In Formula 1, n4 is 0, and n1, n2 and n3 are each independently 1, In formula 1, when n4 is 0, T 4 does not exist, R in formula 1 and 2 1 -R 4 and Q 51 -Q 53 Each independently is: Hydrogen, deuterium, C 1 -C 20 Alkyl, C 2 -C 20 Alkenyl, C 1 -C 20 Alkoxy, or C 1 -C 20 Alkylthio; Each of C is substituted by 1 -C 20 Alkyl, C 2 -C 20 Alkenyl, C 1 -C 20 Alkoxy, or C 1 -C 20 Alkylthio: deuterium, -CD 3 、-CD 2 H.-CDH 2 , C 1 -C 10 Alkyl, or any combination thereof; or cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclopentenyl, cyclohexenyl, cycloheptenyl, cyclooctenyl, cyclopentadienyl, cyclohexadienyl, cycloheptadienyl, cyclooctadienyl, cycloheptatrienyl, cyclooctatrienyl, phenyl, biphenyl, terphenyl, or naphthyl, each unsubstituted or substituted with: deuterium, -CD 3 、-CD 2 H.-CDH 2 , C 1 -C 20 Alkyl, deuterated C 2 -C 20 Alkyl, C 1 -C 20 alkoxy, or any combination thereof, and Q in Formula 2 51 -Q 53 None is hydrogen, Q in Formula 2 51 -Q 53 At least one of the following is independently phenyl, biphenyl, terphenyl, or naphthyl, each of which is unsubstituted or substituted with: deuterium, -CD 3 、-CD 2 H.-CDH 2 , C 1 -C 20 Alkyl, deuterated C 2 -C 20 Alkyl, C 1 -C 20 Alkoxy, or any combination thereof, a1-a4 in Formula 1 are each independently an integer of 0-20, L in Formula 2 1 is a single bond, In formula 2, c1 is an integer from 1 to 10. c2 in Formula 2 is an integer from 1 to 20, * indicates the binding site with the adjacent atom, and In formula 1, The group represented by is represented by one of the formulas CY1-26 to CY1-41: Among them, in formulas CY1-26 to CY1-41, X 1 For C, R 11 is phenyl which is unsubstituted or substituted with: deuterium, -CD 3 、-CD 2 H.-CDH 2 , C 1 -C 20 Alkyl, deuterated C 2 -C 20 Alkyl, C 1 -C 20 Alkoxy, or any combination thereof, R 12 -R 15 Each reference R 1 The description of R 12 -R 15 Each is not hydrogen, * represents the binding site with M in Formula 1, and *' represents the difference between T and 3 The binding site In Formula 1, ring CY 2 It is expressed by the formula CY2(1): Among them, in formula CY2(1), X 2 For C, *' represents the difference between T and 3 The binding site * represents the binding site with M in Formula 1, and *" indicates the same as T in formula 1 1 The binding site In Formula 1, ring CY 3 It is represented by one of the formulas CY3(1) to CY3(7): Wherein, in formulas CY3(1) to CY3(7), X 3 For C, X 31 is a single bond, *" indicates the same as T in formula 1 1 The binding site * represents the binding site with M in Formula 1, and *' represents the difference between T and 2 The binding site In Formula 1, ring CY 4 It is represented by the formula CY4(1): Among them, in formula CY4 (1), X 4 For N, * represents the binding site with M in Formula 1, and *' represents the difference between T and 2 The binding site, and The organic metal compound represented by Formula 1 does not include compound Pt-1 2. The organometallic compound as claimed in claim 1, wherein X in Formula 1 1 The bond between M is a coordination bond.

3. The organometallic compound as claimed in claim 1, wherein the *-C(Q 51 )(Q 52 )(Q 53 ) is represented by one of formulae 2-1 to 2-20: in, In formulas 2-1 to 2-20, Q 51 and Q 52 Each independently is as claimed in claim 1 for Q 51 and Q 52 The substituted or unsubstituted C 1 -C 20 Alkyl or substituted or unsubstituted phenyl, Q 61 -Q 65 Each independently is C 1 -C 20 Alkyl or deuterated C 1 -C 20 Alkyl, where Q 51 , Q 52 , and Q 61 -Q 65 are the same or different from each other, and * represents the same as L in Formula 2 1 binding site.

4. The organometallic compound according to claim 1, wherein the organometallic compound is one of the following compounds:

5. An organic light emitting device, wherein include: a first electrode; a second electrode; as well as an organic layer disposed between the first electrode and the second electrode and including an emission layer, The organic layer comprises at least one organic metal compound as claimed in any one of claims 1 to 4.

6. The organic light emitting device according to claim 5, wherein The first electrode is an anode, The second electrode is a cathode, and The organic layer further includes a hole transport region disposed between the first electrode and the emission layer and an electron transport region disposed between the emission layer and the second electrode, wherein the hole transport region comprises a hole injection layer, a hole transport layer, an electron blocking layer, a buffer layer, or any combination thereof, and The electron transport region includes a hole blocking layer, an electron transport layer, an electron injection layer, or any combination thereof. The organic light emitting device of claim 6 , wherein the emission layer comprises the organic metal compound. The organic light emitting device of claim 7 , wherein the emission layer further comprises a host. 9 . The organic light emitting device of claim 7 , wherein a ratio of an emission component emitted from the organic metal compound is 80 percent (%) or more of a total emission component emitted from the emission layer.

10. The organic light emitting device of claim 9, wherein blue light is emitted from the organic metal compound.

11. The organic light emitting device of claim 7, wherein the emission layer further includes a fluorescent dopant different from the organic metal compound, and a ratio of an emission component emitted from the fluorescent dopant is 80% or more of a total emission component emitted from the emission layer. 12 . The organic light emitting device of claim 11 , wherein the fluorescent dopant comprises a compound including an amino group.

13. An electronic device comprising the organic light emitting device according to any one of claims 5 to 12.

Citation Information

Patent Citations

  • Organometallic compound, organic light emitting device including the same and electronic apparatus including the organic light emitting device

    KR1020210065868A

  • Cyclometallated Tetradentate Pt (II) Complexes

    CN103102372A

  • Platinum complexes and devices

    CN104693243A

  • Blue light emitting platinum complex material and organic light emitting device

    CN108840886A

  • Organic electroluminescent materials and devices

    CN109309168A